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Prevention and treatment of progressive experimental glomerulone.
phritis with type IV phosphodiesterase inhibitor. S. Agarwal, F. W.K. Tam,
J. Smith, D. Morel, EM. Thompson, and C.D. Pusey, Renal Unit and
Department of Histopathology, Royal Postgraduate Medical School, London,
England, United Kingdom. TNF-a has an important role in acute glomer-
ular inflammation. Rolipram, a type IV phosphodiesterase inhibitor, has
multiple anti-inflammatoiy effects including inhibition of TNF-a synthesis.
We investigated the effects of rolipram in a model of crescentic glomer-
ulonephritis in WKY rats in two sets of experiments. Glomerulonephritis
was induced by injection of nephrotoxic serum (NTS). In both experi-
ments, rats were injected i.p. with either 6.25 mg/kg of rolipram or vehicle
only twice daily. In the first experiment, the first injection of either
rolipram or vehicle was given 2.5 hours before injection of NTS, and rats
were killed 96 hours later. By 96 hours, vehicle treated rats (N = 6)
developed glomerular injury which was significantly abrogated by rolipram
treatment (albuminuria 14.9 11.8 mg/17 hr vs. 0.04 0.03 mg/17 hr,P <
0.01; focal segmental necrosis with fibrin deposition affecting 7.7 2.4%
of glomeruli vs. 0.3 0.3% of glomeruli, P < 0.01). In the second
experiment, treatment was started 96 hours after injection of NTS. By day
7 after injection of NTS, rolipram treated rats (N = 6) had significantly
less albuminuria than vehicle treated rats (N = 6; 82.5 10.7 mg/17 hr vs.
133.2 14.9 mg/17 hr, P < 0.05). These rats were killed 7 days after
injection of NTS. Glomeruli from the rolipram treated rats had less focal
segmental damage (23.7 4.4% vs. 52 4.9%, P < 0.01) and fewer
crescents than the vehicle treated rats. Renal production of TNF-a was
assessed by measurement of serum and urinary TNF-a by ELISA. On day
7, urinary TNF-a was lower in the rolipram treated rats (139 54 pg/17
hr vs. 372 79 pg/17 hr, P = 0.05). TNF-a was not detected in the sera
from either group of rats. We conclude that rolipram is effective in both
prevention and treatment of experimental anti-glomerular basement
membrane glomerulonephritis. This effect was associated with reduction
of renal production of TNF-a.
Arginase activity in nephritic glomeruli is inhibited by hydroxyarginine(HOArg) and increased by IL.4. SN. Waddington, V. Cattell, and H. T
(Jook, Department of Histopathology, St. Ma,y's Hospital Medical School,
London, England, United Kingdom. Arginase activity is present in mesan-
gial cells and nephritic glomeruli. Arginase converts arginine into orni-
thine, a precursor of proline and polyamines, and urea and competes for
arginine with nitric oxide synthase. There is recent evidence that HOarg,
an intermediate in the conversion of arginine to nitric oxide, and IL-4
modulate arginase activity in macrophages. We therefore examined their
effect in ncphritic glonieruli. Glomeruli from rats with accelerated neph-
rotoxic nephritis (day 4), normal rat glomeruli, rat mesangial cells, and rat
thioglycollate-elicited macrophages were assayed for arginase activity (14C
arginine to urea conversion) after a 48 hr incubation with or without
HOArg (200 /.LM) and IL-4 (80 ng/ml). Arginase activity was increased in
nephritic glomeruli, as reported previously (Jansen et al. Kidney mt
42:1107-1112, 1992). HOArg suppressed arginase activity in nephritic
glomeruli, macrophages, cultured mcsangial cells and normal glomeruli.
1L-4 increased arginase activity in nephritic glomeruli and macrophages
but not in mesangial cells or normal glomeruli (Table).
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Arginase activity (nmol urea/48 hr) SE
Day 4
Normal Nephritic Mesangial
glomeruli glomeruli cells
per 2000
gloms.
per 2000
gloms.
Macrophages
per 106 cells
per mg
protein
Basal 9.3 1.7 20.5 35C 7.1 0.3 279 8
+HOarg 2.7 0.4k' 9.1 4.1 125 5'
7.7± 1.9 85.5 219h 26.1 14h 287 8
a Day 7 glomeruli showed a similar response
P < 0.001 vs. Basal
aP < 0.05 vs. Normal glomeruli
These results show that the response in nephritic glomeruli is similar to
macrophages. In contrast normal glomeruli behave more like basal
mesangial cells. This is the first demonstration that arginase activity can be
modulated in glomcruli and cultured mesangial cells. Both HOArg and
IL-4 may influence the progression of glomerulonephritis.
Hemin, an inducer of haem oxygenase, ameliorates experimental
nephrotoxic nephritis. T. Cook, K. Mosley, V. Cattell, Department of
Experimental Pathology, Imperial College School of Medicine at St. Mary's,
London, England, United Kingdom. Haem oxygenase is the rate limiting
enzyme in haem metabolism, catalyzing the degradation of haem to
biliverdin, iron and carbon monoxide. Two isoforms exist, a constitutive
form and an inducible form (HO-i) which can be induced in mesangial
cells by cytokine stimulation. In vivo induction of HO-I has anti-inflam-
matory and anti-oxidant effects. We have looked for HO-i in accelerated
nephrotoxic ncphritis (NTN) and examined the effect of hemin, an inducer
of HO-I. Male Lewis rats were preimmunized with rabbit IgG and
Freund's complete adjuvant 7 days before intravenous rabbit nephrotoxic
globulin (NTG). Hemin (30 .tmol/kg; N = 3) or saline vehicle (N = 3) was
administered subcutaneously 24 hours before and 48 hours after NTG.
Proteinuria was measured in urine collected from day 0-1 and day 3-4.
Renal biopsies were taken at 24 hours and rats were killed at day 4.
Formalin fixed paraffin embedded sections were stained with H&E for
assessment of glomerular thrombi and immunohistochemistry was per-
formed for HO-i and macrophages (EDI). HO-l was not detected
imniunohistochemically in normal glomeruli, but was induced in glomeruli
in NTN at days 1 and 4. Double labeling showed that at day 4 the majority
of HO-I expressing cells were macrophages. Proteinuria was reduced on
day 0-1 (hemin 33 15 mg/24 hr control 79 5, P < 0.05) and day 3-4
(22 9 mg/24 hr; control 72 12, P < 0.05) as was glomerular
macrophage infiltration on day 1(14.3 2.5 cells/glum; control 18.2 1.1,P = 0.1) and day 4 (10.2 1.2 cells/glum; control 15.6 0.5, P < 0.05).
Glomerular thrombi were counted as the mean number of glomerular
quadrants involved and were reduced by hemin at day 1 (0.24 0.13;
control 1.53 0.49, P < 0.05). We conclude that HO-I is induced in NTN.
Stimulation of its synthesis with hemin leads to a reduction in glomerular
thrombosis, macrophage infiltration and proteinuria. The mechanism
remains to he determined, but possibilities include anti-complement or
anti-oxidant effects of hiliverdin, and vasodilator and anti-platelet eficts
of CO.
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Polarity of TGF-J1 stimulation by proximal tubular cells. A. 0. Phillips,
K Morrisey, R. Steadman, and J.D. Williams, Institute of Nephrology, Royal
Infirmary, Cardiff Wales, United Kingdom. We have previously demon-
strated that treatment of human proximal epithelial cells with 25 mvi
D-glucose induces the mRNA for TGF-f31, but protein synthesis is
initiated only by the subsequent application of PDGF. To investigate
whether there is a selective polarity to this stimulation and to determine
the polarity of TGF-j31 synthesis we have grown LLC-PKI cells on porous
tissue culture inserts. Once confluent (assessed by transepithelial resis-
tance), cells were treated with 25 mtvi D-glucose on either their apical or
basolateral aspect. TGF-131 mRNA induction (RT-PCR) occurred only
following basolateral application. TGF-pl secretion was induced only by
the subsequent application of PDGF to the basolateral aspect of the cells,
and was detected equally in the apical and basolateral compartments. This
effect was maximal after 48 hr PDGF stimulation and represented a 3-fold
increase over controls for TGF-/31 in both the apical and basolateral
compartments (N = 3, P < 0.05 vs. control). The glucose transporter
inhibitors, phlorizin and phloretin, were used to investigate this effect on
specific D-glucose transport. Application of either basolateral phlorizin or
phloretin at the time of addition of 25 mtvi D-glucose to the same
compartment inhibited PDGF stimulated TGF-131 synthesis. Maximal
inhibition was achieved at 0.5 m of either inhibitor (Phlorizin %
inhibition of apical TGF-131, 75%, P = 0.015, basolateral TGF-131, 78%
P = 0.015; Phloretin % inhibition of apical TGF-131, 68%, P = 0.03,
basolateral TGF-131, 79% P = 0.001, N = 5, P vs. control). No inhibition
was seen with apical application of either inhibitor. These data demon-
strate that priming of proximal tubular cells for TGF-j31 synthesis results
from basolateral exposure of the cells to 25 mM D-glucose. Based on the
known activity of phiorizin and phloretin, they further suggest that this
mechanism is dependent on the activity of the basolateral D-glucose
transporter GLUT-I.
Macrophages modulate the pro-sclerotic responses of mesangial cells.
I.Z.A. Pawluczyk and KP.G. Harris, Department of Nephrology, Leicester
General Hospital, Leicester, England, United Kingdom. Glomerulosclerosis
(GS) is the final outcome of a number of different causes of glomerular
injury during which the structures of the glomerulus are obliterated by
extracellular matrix. Accumulating evidence suggests that macrophages
(mb) play a pivotal role in the pathogenesis of this process. We previously
reported that macrophage conditioned medium (MPCM) stimulates mes-
angial cells to secrete fibronectin (Fn). We have now examined other
pro-sclerotic effects of MPCM on mesangial cells (MC). The genes for the
matrix proteins laminin and collagen IV, as well as fibronectin, were
up-regulated (4.94 0.17-, 3.03 0.31- and 2.86 0.24-fold, respectively,
P < 0.001). mRNA for tissue inhibitor of metalloproteinases (TIMP-1)
was also increased (15.2 2.5, P < 0.001), suggesting that a decrease in
degradation rate could contribute to Fn accumulation. Although the genes
(and the proteins) for the pro-fibrogenic growth factors TGFI3I and
PDGF were also increased in response to MPCM (2.2 0.4, P < 0.001,
5.7 1.2, P < 0.004, respectively), the use of suranim (a growth factor:
receptor binding antagonist) and neutralizing antibodies to these cyto-
kines suggested that these growth factors only played a minor role in
MPCM stimulated MC Fn production. MC expression of MCP-1 mRNA
was augmented 5.8 0.8 fold (P < 0.001) in response to MPCM
suggesting that m1 can stimulate their own recruitment and activation by
establishing a positive autocrine feed back loop. TGF1 (25 nglml)
pretreatment of macrophages prior to the generation of MPCM signifi-
cantly reduced the ability (by 43.1 2.6%, P < 0.001) of the MPCM to
induce MC FN secretion, suggesting that TGF1, as well as inducing
pro-fibrogenic effects, may provide a counter-regulatory mechanism
whereby the matrix inducing factor(s) of m1 are suppressed. In conclu-
sion, these data demonstrate that infiltrating glomcrular m0' play a pivotal
role in the regulation of the sclerotic process by MC.
Enhanced uptake of LDL and oxidized LDL (OxLDL) by endothelial
cells in uremic plasma. R.C. Thuraisingham, G. yR. Born, 7vf.M. Yaqoob,
and L.E. Cardonna-Sanclemente, Anthony Raine Research Laboratory,
Royal Hospitals Tmst and Pathopharmacology Unit, William Harvey Re-
search Institute, St. Bartholomew's Hospital, London. Endothelial abnor-
malities and increased oxidant stress are recognized features of the uremie
syndrome. These features are generally accepted as predictors of in-
creased cardiovascular morbidity and mortality. Our hypothesis is that one
such abnormality is altered LDL and Ox-LDL fluxes in endothelial cells
under uremic conditions. In order to test this hypothesis, we examined the
uptake of these lipoproteins by human microvaseular endothelial cells
(HMEC) under uremic and control conditions. Human LDL, prepared by
sequential ultraeentrifugation, was labelled with '251-tyramine cellobiose
(1251-TC). Following cellular uptake, the lipoprotein is degraded and
removed; however, the labelled adduct remains, indicating the total LDL
flux. OxLDL was obtained using the copper technique. Uremic plasma
(Ur) was collected from male non-diabetic hemodialysis patients just prior
to a dialysis session. Control plasma (Con) was obtained from healthy
male volunteers. HMEC were grown on 24 well plates at 6 X 105/well at
37°C in 5% CO2. Starved cells were then incubated with medium
supplemented with 10% control or uremic plasma for 0, 4, 14, 24 hours in
the presence of either 1251-TC-LDL or 251-TC-Ox-LDL. At the end of the
incubations, supernatants were collected and three PBS washes per-
formed. The cells were then trypsinized, harvested and their radioactivity
counted in a y-counter. Results are expressed as mean SuM counts per
well. Statistical analysis was by Student's t-test for unpaired data.
Time, hours
LDL
Con (N = 6) Ur (N = 6) P
0
4
14
24
7150 1208
59090 5368
222485 20696
279486 23577
6693 717
72603 5820
280356 20028
351003 22912
NS
NS
<0.04
<0.03
Time, hours
OxLDL
Con (N = 6) Ur (N = 6) P
0
4
14
24
7957 1462
79760 12729
264868 32258
358450 42088
8415 1462
110823 13466
336524 21673
447593 33234
NS
<0.01
<0.05
<0.02
These data indicate an increased flux of LDL and Ox-LDL into endothe-
hal cells under uremic conditions. The reasons and consequences of these
findings and the effect of the increased lipoprotein flux on nitric oxide
metabolism will be the subject of future work.
Ligation of ICAM-1 on the surface of renal cortical fIbroblasts stimu-
lates de novo expression of ICAM-1 and VCAM-1. A. Clayton, J.D.
Williams, and R. Steadman, Institute of Nephrology, University of Wales
College of Medicine, Royal Infirmary, Cardiff Wales, United Kingdom.
Progression to end-stage renal failure is accompanied by renal interstitial
inflammation and fibrosis in which the activity of resident fibroblasts is
believed to be of central importance. Intracellular adhesion molecule
(ICAM)-1 has been implicated as the principal adhesion molecule con-
trolling leukocyte infiltration of the inflamed interstitium. We have
reported previously the isolation of fibroblasts from the normal renal
cortex and shown that, following treatment with inflammatory cytokines,
they increased their expression of ICAM-1 and bound peripheral blood
neutrophils and monocytes in a manner that was dose-dependently
inhibited by anti-CD 18 antibodies. This interaction of the fibroblasts with
leukocytes triggers an influx of extracehlular calcium ions and is mimicked
by specifically cross-linking the ICAM-1 receptor with anti-IAM-1
antibodies. The present study tested the hypothesis that one effect of
cross-linking ICAM-l on the surface of the cell is to stimulate the de novo
synthesis and expression of cellular adhesion molecules. Following cross-
linking there was a 2- to 3-fold increase in the steady-state levels of
ICAM-1 mRNA. The expression of this mRNA peaked at 1—3 hours and
was dose-dependent on the concentration of secondary cross-linking
antibody. There was no response as a result of incubation with irrelevant
antibody (anti-ELAM-1). The expression of ICAM-1 protein was also
increased in response to cross-linking pre-formed ICAM-1. Peak protein
expression was between 18 —48 hours after cross-linking and was also
dependent on the concentration of cross linker. Additional data demon-
strated a similar increase in the expression of VCAM-1 following lAM-l
cross-linking. Preliminary studies using BAPTA-AM to chelate intracel-
lular calcium ions suggest that the up-regulation of adhesion molecules is
partly triggered as a result of the associated flux of calcium ions. The
present study demonstrates that interstitial fibroblasts can be stimulated
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by the direct cell surface interaction of ICAM-1 with its ligands on
inflammatory cells. One phenotypic change resulting from this interaction
is the up-regulated synthesis and expression of more cellular adhesion
molecules. This may have profound implications for the role of the
fibroblasts in controlling the progression of inflammatory renal disease.
Golgi co-localisation of TNFR1 and signalling proteins in endothelial
cells. S.J. Jones, K. Wolfreys, J. Savidge, and J. Bradley, Department of
Medicine, University of Cambridge, Cambridge, England, United Kingdom.
Tumor necrosis factor receptor 1 (TNFR1) can initiate intracellular signal
transduction pathways which induce apoptosis or activate NF-KB. Insight
into the molecular mechanisms involved has been provided by the
identification of receptor associated signalling proteins containing death
domain (TRADD) and TRAF domain (TRAFI and TRAF2) motifs. We
have previously demonstrated, by confocal immunofluorescence and
electron microscopy, that the TNFRI is Golgi and the TNFR2 is plasma
membrane-associated. This disparate localization of the two receptors
may have important implications with respect to endothelial cell activa-
tion. We aimed to determine whether signalling proteins, importantly
TRADD and TRAF2, are also co-localized with the TNFR1 in the Golgi.
Human umbilical vein (HUVEC) and a spontaneous human endothelial
cell line (ECV304) were subjected to subcellular fractionation using
differential and sucrose density gradient ultracentrifugation techniques.
The interfaces were assayed for enrichment of the Golgi enzyme marker
alpha mannosidase II and Western blotted using antibodies to the Golgi
specific marker p58, TNFRI, TNFR2, TRAF2 and TRADD. Antibodies
to TNFR1, TRAF2 and p58 proteins specifically immunoblotted proteins
of approximately 60 kDa, 56 kDa, and 58 kDa, respectively from Golgi
enriched fractions. However, TNFR2 and TRADD were not recognized in
this fraction. Using confocal microscopy anti-TRAF2 antibodies exhibited
cell surface, Golgi and nuclear staining, hut no detectable staining was
observed with anti-TRADD antibodies. This study confirms that in
endothclial cells the TNFR1 is Golgi-associated and further demonstrates
the presence of TRAF2 in the Golgi. The effect of TNF on localization
and expression of TRADD, which is required to bridge TRAF2 to
TNFR1, is under investigation.
mRNA estimation in single human glomeruli by competitive RT.PCR:
Methods and initial applications. L.L. Hall, G.R. Bicknel4 J.A. Shaw, J.H.
Pringle, and P.N. Furness, Department of Pathology, Leicester Royal Infir-
mary, Leicester, England, United Kingdom. Measurement of a specific
mRNA in a tissue is often the best available index of that tissue's rate of
synthesis of the corresponding protein. Needle biopsies are too small for
Northern blotting; in situ methods give localization but poor quantitation.
The best quantitative method for small samples is reverse transcriptase-
polymerase chain reaction (RT-PCR) with initial addition of a known
amount of a competitor strand (competitive RT-PCR) to permit quanti-
tation of specific mRNA sequences. Single glomeruli can be obtained
either by plucking them by hand from the surface of fresh renal biopsies,
or by washing the biopsy needle after the procedure. mRNA is extracted
from a single glomerulus using oligo-dT-linked paramagnetic beads.
Reverse transcription and PCR are carried out conventionally. Where
appropriate, a competitor strand is added; we have developed a novel
ligase-free PCR approach to the synthesis of these strands. Detection of
the amplified product is by an ELISA-based plate assay with specific
digoxygenin-labelled oligonucleotide probes. This facilitates rapid and
specific measurement of native and competitor products, without electro-
phoresis. The bead-linked eDNA is stable, and eDNA from one glomer-
ulus can he used for at least 20 separate mRNA estimations, or consid-
erably more if bead-linked eDNA is re-used with different primers. The
method is also applicable to sections of frozen tissue, including archival
material. Extraction of mRNA from glomerular epithelial cells alone can
be achieved, but this has been limited by unpredictable contamination by
mesangial mRNA. We have applied these methods to "housekeeping
genes" (GAP3DH and 1l-aetin), cytokines, extracellular matrix molecules,
degradative enzymes, and enzyme inhibitors. Initial results suggest that in
glomeruli from stable renal transplants, levels of mRNA for collagen III
and collagen IVa2 correlate with levels of TGF. Glomeruli from cases of
IgA nephropathy show considerable variation in expression of collagen III
and collagen IVcs2, hut expression of collagen TVa5 is comparatively
stable, supporting recent reports that a2, hut not 5, is involved in
glomerular sclerosis.
Growth of metanephric endothelia in a realistic experimental milieu. S.
Loughna, P. Hardman, K. Alitalo, L. Jussila, and AS. Woolf Developmental
Biology Unit, Institute of Child Health, London, England, United Kingdom,
and University of Helsinki, Helsinki, Finland. Previous observations sug-
gested that embryonic kidney vessels formed by in-growth, or angiogene-
sis, because explanted murine metanephroi were invaded by avian eho-
rioallantoic membrane (CAM) vessels and also formed avascular
glomeruli in organ culture. Our recent studies, however, found that
avascular embryonic day II (Eli) metanephroi and cell lines derived from
El 1 renal mesenehyme expressed vascular endothelial growth factor and
its receptor tyrosine kinases (RTK) VEGFR 1/2. Thus, the molecules for
vasculogenesis, or in situ vessel formation, are present at the onset of
nephrogenesis. The orphan RTK, TIE-I, is expressed early in the endo-
thelial lineage and we have detected TIE-I mRNA at the inception of
nephrogenesis. In TIE-I promoter/LacZ transgenie mice, the expression of
the reporter gene was detected in vivo in E12 metanephroi in sparse
capillaries around the ureterie bud and also in isolated mesenchymal cells
which we postulate are either endothelia differentiating in situ or anglo-
blasts which have migrated into the organ. Next, we transplanted these
metanephroi into the renal cortex of non-transgenie neonates, a site
known to permit growth of implants into filtering nephrons. Chimeric
kidneys were harvested at nine days and differentiated implants were
detected which contained a rich vascular network with transgenic endo-
thelia in clefts of S-shaped bodies and in glomerular arterioles and
capillaries. In contrast, when E12 rudiments were grown in organ culture
or in the chick CAM only a few transgenie vessels were detected despite
glomerular differentiation. Hence, we conclude that the growth of embry-
onic kidney endothelia and their precursors is only favored when the
experimental setting closely mimics the conditions which are normally
found in vivo.
Hyperglycemia induces cytochrome P450 in proximal tubular cells. M.
Varagunam and M. Yaqoob, Anthony Raine Research Laboratories, St.
Bartholomew's Hospital, London, England, United Kingdom. The cyto-
chrome P450 (CYP4SO) family has mainly been studied in the context of
its ability to metabolize xenobiotics into exeretable hydrophilic com-
pounds which are known to cause cellular damage. Insulin deficiency has
been shown to alter the CYP4SO profile in the livers of streptozin-induced
diabetic rats. The number of P450 isoforms varies between species.
CYP2EI has been shown to produce reactive oxygen species such as
superoxide radicals and hydrogen peroxide in high amounts relative to
other P450 isoforms. Evidence of free radical generation and oxidant
injury has been shown in patients, with diabetes mellitus and particularly
in those with diabetic nephropathy. However, the source and cellular
mechanism of free radical generation is not known. We therefore consid-
ered this study to assess the effects of hyperglycemia on the CYP45O
profile in renal proximal tubular cells. Cells from a porcine proximal
tubular cell line (LLC-PK1) were grown in DMEM containing either high
(25 mM) or normal (5 mM) glucose and 10% FCS for one week, in a 5%
C02, 37°C incubator. The cells were washed, harvested and sonicated in
ice cold buffer A (0.25 M K2P04, 0.15 M KCI, 1 mat EDTA, pH 7.25). The
sonicate was spun for a further 60 minutes at 38,000 rpm. The resulting
microsomal pellet was resuspended in buffer B (0.25 M K2P04, pH 7.25,
30% glycerol) and the protein concentration determined by the Lowry
assay. The mierosomal fraction was subjected to Western blot analysis
using a specific CYP2EI antibody and developed using ECL reagents.
There was a threefold increase in CYP2EI in cells grown in hyperglycemic
medium. These preliminary results suggest that hyperglycemia induces
increased levels of CYP2EI protein in LLC-PK1 cells. The significance of
this increase will be the subject of future work.
Apoptosis: A mechanism of cell deletion in an experimental model of
chronic renal failure. G.L. Thomas, B. Yang, and AM. El Nahas, Sheffield
Kidney Institute, Northern General Hospital Trust, Sheffield, England, United
Kingdom. The model of 5/6 subtotal nephrectomy (SNx) in age-matched
male Wistar rats (University of Sheffield Strain) has been used to study
chronic renal failure and progressive fibrosis in the remnant kidney.
Tissues were excised from experimental (SNx) and control (SNe) animals
on 7, 30, 90 and 120 days post-SNx. These were examined for morpho-
logical signs of apoptosis by H&E staining, electron microscopy and
acridine orange fluorescent staining of nuclear chromatin; and for signs of
DNA cleavage by endonueleases via the principal of TUNEL staining
(Apop Tag). Maximal apoptosis is seen at day 9t) when the increase with
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respect to controls being 21.5-fold (P < 0.006) for glomerular cells,
7.1-fold (P < 0.001) for interstitial cells and 14.2-fold (***P < 0.0001) for
tubular cells. In conclusion, we have shown a time-dependent increase in
apoptosis in the subtotal nephrectomy model of chronic renal failure. This
may contribute to the progression of tubular atrophy and play a role in the
pathogenesis of tubulointerstitial scarring.
The effect of acidosis and insulin upon protein degradation in cultured
muscle cells. R.G. Roberts, C.P.F. Redfern, and T.H.J. Goodship, Depart-
ment of Medicine, University of Newcastle upon Tyne, Newcastle upon Tyne,
England, United Kingdom. That acidosis increases protein degradation in
chronic renal failure is well-established. We believe that this is mainly due
to increased activity of the ubiquitin-dependent proteolytic pathway. We
have used the L6 rat myoblast line together with primary cultures of
human muscle to investigate this further. Using 14C-phenylalanine release
to measure protein degradation (PD) we found an increase (expressed as
log % of initial cellular 14C/hour) from —3.4 0.3 X iO at pH 7.40 to
—4.4 0.3 )< iO at pH 6.95 in L6 cells. Addition of 100 nM insulin
reduced PD under both conditions. In a separate experiment we found a
dose-response relationship between PD and insulin with a just significant
effect using 1 nM insulin. We obtained the same pattern of results with
human myocytes. Using Northern blotting to investigate the ubiquitin-
dependent proteolytic pathway, we found that in L6 cells insulin reduced
the expression of the main components of the pathway, ubiquitin (UbA &
UbB), activating enzyme El, conjugating enzyme E2 and proteasome
component C2. In the presence of insulin plus acidification, the expression
of UbB, E2 and El was higher than with insulin alone, whereas the other
genes were sensitive to insulin despite the acid pH. We did not find
increased expression of any of the genes in the presence of acid alone. In
the human cells we found that insulin reduced the expression of E2 but did
not affect ubiquitin expression (Renal Association 1995). Regulation of
this pathway by insulin supports the hypothesis that it is important in
acidosis. That ubiquitin expression was not up-regulated by acidosis in L6
cells may be a consequence of the model, perhaps because the genes are
already highly expressed in these cells.
Fatty acids on albumin cause injurious effects in protein overload
proteinuria. ME. Thomas, N.J. Bninskill, S.J. Harper, K.P.G. Harris, P.N.
Furness, and J. Walls, Department of Nephrology, Leicester General Hospital,
Leicester, England, United Kingdom. Interstitial inflammation is a charac-
teristic finding in protein overload proteinuria. To investigate whether the
fatty acids carried on injected albumin mediate these deleterious effects,
two g per day of fatty acid bearing (FA-BSA, N = 7) or delipidated(DL-BSA, N = 7) bovine serum albumin were injected intraperitoneally
into female Lewis rats for 7 days. Kidneys were perfused in situ with saline
on day 7. Cortical macrophage (MCI)) infiltration was measured by
immunoperoxidase staining with an ED-i antibody. Percent area stained
was measured blindly using the program NIH Image to analyze video
images of the Sections. S phase cells were identified by in situ hydridization
for histone mRNA, and counted blindly per high power field. Results
shown are means (suM). Groups were compared by Mann-Whitney tests.
Urine protein (U) mg/day
_________
Day 1 3 6
FA-BSA 634 1078 986
(179) (60) (93)
DL-BSA 688 561 704
(72) (129) (102)
P 0.49 0.01 0.04
MCI S-phase_cells/hpf
% Tubular Interstitial
7 7 7
0.99 2.38 0.99
(0.15) (0.35) (0.19)
DL-BSA 0.47 1.47 0.44
(0.11) (0.31) (0.08)
P 0.02 0.10 0.04
Serum BSA levels were similar in both groups. FA-BSA provoked a
significantly greater cortical MCI influx and tubulointerstitial cell prolifer-
ation than DL-BSA. FA-BSA produced higher U, levels at days 3 and 6
than DL-BSA, suggesting greater glomerular epithelial injury. The admin-
istration of DL-BSA, compared to FA-BSA, is associated with reduced
renal injury. This is characterized by a marked reduction in the tubuloin-
terstitial abnormalities seen in protein overload proteinuria. In conclu-
sion, the fatty acids carried by BSA have deleterious effects in protein
overload proteinuria.
Renal papillary interstitial fluid osmolality in experimental uremia.
R.M. Chamberlain, J. Skinner, and D. G. Shirley, Department of Physiology,
Charing Cross & Westminster Medical School, London, England, United
Kingdom. The pathophysiology of the impaired urine concentrating ability
of chronic renal failure is ill-understood. Concentration of urine is
dependent on two factors: hypertonicity of the medullary interstitium and
vasopressin-induced water transport in the collecting ducts. The latter may
be impaired in renal failure, owing to down-regulation of the V2 receptor.
In the present study we have investigated the osmolality of the papillary
interstitium in uremic rats. Rats were subjected to either two-stage 5/6
nephrectomy (5/6 NX) or sham operations (SO). In 5/6 NX rats, urine flow
rate (V) increased 2—3 fold and urine osmolality (U,,,) was reduced.
After 5 weeks, the rats were anesthetized (thiopental, 110 mg/kg, i.p.) and
clearance measurements made. Relevant data (means SEM, N = 8 per
group) are shown below.
GFR
mi/mm
PUN
mmol/liter
V
p1/mm
SO
5/6 NX
3.1 0.1
0.8 0.la
7.4 0.7
15.0 0.8
8.5 0.3
22.8 2.l
FEH2Q
%
U=
mOsm/kgH2O
SO
5/6 NX
0.3 0.1
3.2 0.5a
2018 337
779 77
Abbreviations are: GFR, glomerular filtration rate; PUN, plasma urea
nitrogen; FE1120, fractional water excretion; < 0.001 compared with
SO group.
Samples of papillary interstitial fluid were obtained by the method of
sequential centrifugation and their osmolalities measured. Papillary os-
molality in SO rats was 1791 140 mOsm/kg H20 (N = 7), but only 620
37 mOsm/kg H20 (N = 7; P < 0.001) in the 5/6 NX group. This
diminished hypertonicity is likely to be a major factor in the reduced
concentrating ability characteristic of experimental uremia.
HDL and protein farnesylation in a tubular cell monolayer model of the
nephrotic syndrome. C.P. Streather, iS. Owen', B.M. Hend,y, and J.E.
Scoble, Renal Unit, Department of Medicine, King's College Hospital, and
Department of Medicine, Royal Free Hospital, London, England, United
Kingdom. Urinary HDL is a marker of unselective proteinuria and
therefore heralds a worse renal prognosis. HDL has been shown to
stimulate renal tubular cells, and this effect is sensitive to Hydroxymeth-
ylglutaryl Coenzyme A (HMG C0A) reductase blockade with simvastatin
(SIM). This effect may be related to the non-sterol products of this
pathway, such as farnesol, since protein farnesylation is necessary for the
biological activity of proteins, such as p21 ras, which are involved in cell
proliferation. LLC-PKI porcine tubular cell monolayers were exposed to
apical, corresponding to urinary, HDL and monolayer resistance and the
synthesis of sterols measured using 14C-acetate as a substrate. The effects
of SIM, farnesol pyrophosphate (FPP), the substrate for farnesol protein
transferase (FPT), and hydroxy farnesyl phosphonic acid (HFPA), a
blocker of this enzyme on monolayer resistance (MR) and sterol synthesis,
were investigated. Three hundred j.rg/mI HDL added atypically to conflu-
ent monolayers, increased MR (initial value = 100% to 341% 88), SIM
totally abolished this effect (MR 49% 16, and 400 jsg/ml) and FPP
partially restored it (MR 154% 53). In further experiments 20 j.LM
I-IFPA significantly reduced the effect of HDL on MR (96% 6 vs. 286%
38; P < 0.002) without reducing sterol synthesis (4.26 0.61 pmol/jsg
Day
FA-BSA
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protein vs. 3.52 0.97 pmol/j.sg protein). SIM significantly reduced sterol
synthesis (0.22 0.03 pmol/jLg protein). Blockers of the protein kinase C
(PKC) system and tyrosine phosphorylation (TK), chelerythrine and
herbimycin A, respectively, had no effect on the resistance response to
HDL. Apical HDL in this model, reproducing urinary HDL in nephrotic
proteinuria, stimulates MR. This effect is sensitive to HMG CoA reduc-
tase and FPT blockade and appears to be independent of effects on
cholesterol synthesis. HDL may therefore act on tubular cells via the
stimulation of protein farnesylation. We speculate that statins might be
used to interrupt this non-sterol pathway and prevent tubular damage in
proteinuria independent of their action on cell cholesterol.
Functional evidence for up-regulation of H ATPase during potassium
depletion. MA. Bailey, R.J. Unwin, and S.J. Walter, Department of Physi-
ology, 'haring Cross and Westminster Medical School and Division of
Nephrology, UCL Medical School, London, England, United Kingdom.
Potassium depletion is associated with metabolic alkalosis and enhanced
bicarbonate reabsorption in the distal nephron. Although the underlying
mechanisms are unclear, we have recently presented immunocytochemical
data that suggest increased expression of H ATPase in the apical
membrane of distal nephron segments. To investigate this possibility in
vivo, we have examined the effect of the specific H ATPase inhibitor,
bafilomycin Al (BAF), on transepithelial potential difference (Vte) in the
late distal tubule of control (N = 5) and potassium-depleted (low-K; N =
5) rats. Animals were anesthetized (mactin; 110 mg/kg i.p.) and prepared
for microperfusion experiments. Distal tubules with at least two accessible
loops were perfused with two solutions designed to mimic early distal
tubular fluid. In addition, amiloride (1 mM), barium (3 mM) and NPPB (10
M) were added to both perfusates in order to abolish possible shunt
pathways: BAF Al (1 M) was included in the second perfusate. Late
distal tubule Vte was recorded during perfusion at 10 nI/mm as previously
described. Perfusion with BAF resulted in the Vte becoming more
lumen-negative in both groups of animals. The absolute change in Vte was
greater (P < 0.05) in the low-K rats (4.7 0.8 my) than in controls (2.5
0.5 mV). The enhanced effect of BAF may indicate increased activity of
eleetrogenie H ATPase during potassium depletion.
Recognition of recombinant rat a3(IV)NCI by autoantibodies from
WKY rats with EAG. J.J. Ryan, J. Reynolds, P.J. Mason, AN. Turner, and
CD. Pusey, Departments of Medicine and Haematology, RPMS London,
London, England; Department of Medicine and Therapeutics, Aberdeen
University, Aberdeen, Scotland, United Kingdom. Goodpasture's disease is
an autoimmune disorder that presents with rapidly progressive glomeru-
lonephritis and lung hemorrhage. It is characterized by pathogenic
autoantibodies to the glomerular basement membrane (GBM), which
recognize the non-collagenous domain of the a chain of type IV collagen,
a 3(IV)NCI. We and others have found evidence that a3(IV)NCI is also
the target of autoimmunity in experimental autoimmune glomerulone-
phritis (EAG), a model of Goodpasture's disease in the rat which shares
many characteristics with the human condition. In order to investigate
immune mechanisms in this model, we set Out to clone, sequence and
express rat a3(IV)NCI. eDNA encoding part of the rat a3(IV)NCI
domain was obtained by RT-PCR of RNA extracted from rat kidney. A
350 bp DNA fragment was radiolabelled and used to screen a rat kidney
eDNA library. One positive clone of 1,350 bp was isolated from 2 >< i0
pfu. Restriction enzyme digestion, Southern blot analysis and sequencing
confirmed that it contained the a3(IV)NCI sequence. The clone encoded
210 bp of the 5' collagenous triple helical region, 690 bp of the NCI
domain and 450 bp of the 3' non-coding region. The overall sequence
homology with human a3(IV)NCI was 90%. Recombinant rat o3(IV) NCI
was expressed in COS-7 cells, using a mini-collagen chain gene as
previously described. Western blot analysis of COS supernantants showed
that the recombinant molecule was recognized by sera from rats with
EAG, and from patients with Goodpasture's disease, at the predicted
molecular weight of 41 kDa. Rat and human control sera did not bind.
Chimeric molecules, in which parts of the rat cs3(IV)NCI domain are
substituted by sequences from other rat or human a(IV) chains, are being
used to localize B cell epitopes in EAG. This is the first report, to our
knowledge, of the expression of recombinant rat a3(IV)NCI. This work
confirms that a3(IV)NCI is an autoantigen in EAG, and the recombinant
protein will be a valuable tool for further analysis of autoimmune
responses in anti-GBM disease.
Macrophage time of residence in the experimentally inflamed perito-
neum depends upon bacterial strain. M.J. Andrews, D. Wakelin, R.P.
Burden, A. G. Morgan, and J. Savill, City Hospital Renal Unit Nottingham
and University of Nottingham, Nottingham, England, United Kingdom.
Inflammatory macrophages (Mø) have been implicated in both local and
systemic complications of CAPD peritonitis, but little has been known of
factors determining Mø life span in the inflamed peritoneum which, in
turn, may regulate injurious potential of these cells. We investigated Mø
kinetics in a simplified model of peritonitis induced in healthy Balb/e mice
by i.p. administration of 100 million heat killed bacteria in 1.0 ml PBS,
thereby excluding complicating effects of bacterial replication, uremia and
dialysis fluid. Although S. aureus and S. epidermidis both induced pmn
infiltration of similar magnitude, kinetics, and rate of pnin apoptosis, there
were profound differences in the time course of Mø infiltration. Following
i.p. S. aureus Mø number in a 4 ml PBS lavage peaked at 3 days, falling
to baseline by 16 days, whereas with S. epidermidis Mø number remained
maximally elevated at 16 days, suggesting increased time of residence. To
address this possibility we developed a new technique for in vivo "pulse-
labelling" of peritoneal Mø by i.p. administration of the fluorescent stable
cell linker PKH. Cytospin preparations of labelled and unlabelled cells
sorted by FACS confirmed 96% sensitivity and specificity of Mø labelling
by PKH. By following the rate of disappearance of labelled Mø from the
peritoneum we determined that in S. aureus peritonitis Mø half-life was
2.5 0.4 days (mean SEM, N = 6), whereas with S. epidermidis half-life
was significantly longer at 4.75 0.3 days. We conclude that hitherto
unrecognized bacterial factors may regulate the kinetics of the peritoneal
inflammatory response by modulating Mø lifespan, suggesting a new
target for studies of the pathogenesis of CAPD peritonitis.
Improvement of neutrophil function in pyruvate peritoneal dialysis
fluid is related to intracellular pH acidification. D. Kaur, iD. Williams, T
Wilkinson, A. Mahiout, M. Hallett, and N. Topley, Institute of Nephrology,
Dept of Surgery, UWCM, Cardiff Wales, United Kingdom; institute of Cell
and Protein Engineering, Hannover, Germany. Acidic lactate buffered
peritoneal dialysis fluid (PDF) inhibits many cell functions related to
peritoneal host defense. These effects appear to be related to intracellular
acidification mediated by the combination of low pH and lactate concen-
tration. In order to reduce the inhibitory effects associated with lactate
buffered PDF, alternative fluid formulations have been developed. The
present study compares the effects of lactate buffered PDF (Lac-PDF, 40
mM Lactate, pH 5.2) with a solution of identical composition buffered with
pyruvate (Pyr-PDF, 40 mti pyruvate, pH 5.2) and examines their effects on
PMN intacellular pH [pH], and respiratory burst activation measured as
luminol-dependent chemilumineseenee (CL). Exposure of PMN to Lac-
PDF for 15 minutes resulted in significant reduction in PMN CL (RLU).
These were reduced from 2.96 0.32 in control solutes (M199, pH 7.3) to
1.11 0.36 and 0.83 0.21 in solutions containing 1.36 and 3.86%
glucose, respectively (N = 7, P < 0.01). In contrast, exposure to Pyr-PDF
did not significantly reduce the PMN CL response (2.08 0.26 and 1.97
0.13 in 1.36 and 3.86% glucose). Exposure of PMN (N = 3) to Lac-PDF
reduced [pH]1 to a mean of 5.0 after 200 seconds exposure. In contrast, in
Pyr-PDF [pH]1 was only reduced to a mean of 5.7 under the same
conditions. The addition of 5% pooled 4 hour spent dialysate to PMN did
not inhibit the intracellular acidification induced by Lac-PDF but abol-
ished that mediated by Pyr-PDF irrespective of glucose concentration. in
order to further examine the effect of extracellular pH on PMN function,
external pH was maintained at pH 5.2 (with 25 ms Hepes) in the presence
of Pyr-PDF or Lac PDF (1.36% glucose) throughout a 15' exposure
period. Under these conditions both solutions showed substantial inhibi-
tion of PMN CL (Pyr-PDF: 0.39 0.06, Lac-PDF 0.134 0.04 vs. control
2.19 0.22, N = 3, P < 0.05 vs. control for both). These data suggest that
the improved function of PMN following exposure to pyruvate buffered
PDF is related directly or indirectly to its ineffectiveness as a buffer at pH
5.2 and thus its reduced effect on PMN [pH] These features suggest
potential advantages of pyruvate as a buffer in PDF.
Pumped haemofiltration in small/pre-term infants. MA. Lewis, Renal
Unit, Manchester Children s Hospital, Manchester, England, United King-
dom. The management of renal failure in the newborn is difficult. When
dialysis is instituted peritoneal dialysis (PD) is usually the technique of
choice. This can be problematic and impossible in some patients with
pre-existing intra-abdominal pathology. Continuous arteriovenous hemo-
filtrarion (CAVH) has been described in infants, but sick pre-term infants
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are not able to support the circuit. I have devised a means of having
pumped hemofiltration in small/preterm infants (PHIS/PI) and describe
its use in ten patients ranging in size from 750 to 3000 g for periods of 1
to 7 days. Vascular access was achieved through 24 gauge up to 5 French
gauge cannulae in either a peripheral artery or a central vein or through
two central veins. Blood was pumped out using an IVAC 572 infusion
pump and through a Gambro FH22 hemofilter. A second IVAC pump was
used to remove hemofiltrate from the filter and a third to infuse
replacement solution. Removal rate was set to give a clearance of 15
ml/min/1.73 sq.m (45 to 105 mI/hr for the above weight range) and blood
flow rate set to between 5 and 10 times the removal rate (225 to 999 ml/hr).
Heparin was infused into the circuit to prevent clotting of the filter.
Biochemical and fluid balance control was achieved in all infants. Guar-
anteed fluid removal allowed the administration of full nutritional sup-
port. Five patients died when treatment was withdrawn because of an
untreatable underlying problem. One recovered renal function but died
some weeks later from unrelated problems, and four patients survived and
recovered renal function. This system allows a secure means of achieving
fluid and electrolyte control in the pre-term infant. The use of this
technique may allow hemofiltration to become as applicable to pre-term
infants as it is to older children and adults.
Skeletal muscle cell phosphate homeostasis following bicarbonate
hemodialysis. T.R. Ringrose, C.H. Thompson, S. Kumar, G.J. Kemp, D.J.
Taylor, and G.K. Radda, MRC NMR Unit, and Churchill Hospital Renal
Unit, Oxford; Department of Orthopaedics, Liverpool University, Liverpool,
England, United Kingdom. Intracellular transfer of extracellular phosphate
(Pi) during dialysis is suggested as an explanation for inadequate Pi
removal by hemodialysis (HD). Skeletal muscle, comprising 40% of lean
body mass, can act as an important reservoir of Pi, and skeletal muscle free
cytosolie Pi is elevated in CRF. The effect of bicarbonate hemodialysis on
plasma and muscle pH and Pi was examined in six male patients. The right
calf muscle was studied by 31P magnetic resonance spectroscopy immedi-
ately before and after a 4 hour dialysis session (35 mrvi HC03 dialysate).
Plasma arterial pH, pCO2, P°2, HC03, Pi and K were taken from the
fistula within 10 minutes of the MRS study.
Pre-dialysis
Plasma
7.41
Muscle
pH
Plasma Pi
mM
Muscle Pi
mM
7.04 1.66 4.25
Post-dialysis 7.45° 7.03 1.06° 4.57
a P < 0.05 Wilcoxon signed rank test
In the group as a whole, there was no significant change in resting muscle
phosphocreatine, pH or P1, despite significant changes in plasma pH and
Pi. However, paradoxical muscle acidification was seen in 3 patients and
muscle pH changes during dialysis appeared dependent on changes in
arterial HC03 (r =
—0.865; P = 0.06). Changes in muscle Pi during
dialysis correlated with these intracellular pH changes (r = 0.808; P <
0.04). Conclusions: (i) skeletal muscle intracellular acidification can occur
following bicarbonate dialysis and (ii) skeletal muscle intracellular Pi
during dialysis is dependent upon intracellular rather than extracellular
pH changes. This study suggests that other cell compartments, such as
bone, may be more important than skeletal muscle in any sequestration of
Pi that occurs during hemodialysis.
Reuse bicarbonate reservoir for hemodialysis. C.P.R. Soper, M.K.
Lam-Po-Tang, and A. II'odge, St. Helier Hospital, Carshalton, England,
United Kingdom. Bicarbonate buffer for intermittent hemodialysis requires
composition shortly beibre administration. Contemporary systems for
administering bicarbonate are suitable for single use only. We report 12
months' use of a reuse cylindrical reservoir for bicarbonate mixture to
diluent, compatible with most dialysis systems. The cylinder is engineered
from polyearbonate, with an inbuilt sprinkler, and is suitable for autoclav-
ing. Between uses it was cleansed by soaking in 1000 ppm sodium
hypochlorite for 60 minutes and then in a standard washing machine, with
exposure to 60°C for 60 minutes. Each reservoir batch is discarded after 6
months. Dialysate was analyzed for Na, K, HCO3 and ionized Ca.
Dialysate samples and supply water were cultured in tryptone glucose
extract agar weekly at 37°C for 7 days. Over a 2 week period crossover
comparisons in serum bicarbonate were made in 7 patients, with a
commercially available single-use cartridge. Predialysis HCO1 values were
20.3 mmol/liter in the reservoir and 19.5 mmol/liter in the cartridge group
(N = 66, P = 0.816). Dialysate HCO3 was not different (1.86 mmol/liter
lower in reservoirs, P = 0.122, N = 5) and showed no fall over dialyses up
to 4 1/2 hours. Dialysate Na, K, Ca were not different and did not change
significantly. Serum HCO1 levels rose by 5.8 3.0 mmol/liter (SD) and
7.1 4.1 mmol/liter, respectively, (not significant by paired sample
Student's t-testing, N = 13). Since switching patients over to the reservoir,
over the last 12 months our supply water and dialysis water have met the
AAMI and European Pharmaeopoiea standards (although cultured at
37°C) in 100% of dialysate samples (N = 31). Reuse bicarbonate
reservoirs have resulted in a fiscal saving of approximately £50,000,
without compromising alkalization, purity from microbial contamination,
or dialysate composition.
Preliminary experience of metacryloylphosphorylcholine laurylmethac-
rylate coated vascular access catheters. FE. Harris, SR. Nelson, J.C.
Russell, 1< O'Byrne, and T. Sutton, Department of Renal Medicine, King
College Hospital, London, and Biocompatihies Ltd., Farnham, England,
United Kingdom. Prolonged central venous access is required for many
patients requiring hemodialysis. Conventional catheters used for vascular
access are prone to occlusion, poor flow rates, and biofllm deposition.
Angiography catheters coated with the copolymer metacryloylphosphoryl-
choline laurylmethacrylate (MPC:LM), a biomembrane mimic, avoid
these problems. We report our initial experience of MPC:LM coated
catheters for prolonged intravascular placement in patients requiring
hemodialysis. Ten consecutive patients, aged 18—75, presenting with acute
or end-stage renal failure, requiring hemodialysis who were otherwise fit
and well, were randomized to receive either coated or conventional
catheters (N = 5 in each group). Standard 15 cm hemodialysis catheters
were used, and 5 catheters were coated with MPC:LM and repacked to
appear identical to uncoated catheters. Catheters remained in situ for
between 4 and 9 days (median 5 days), and were electively removed. They
were fixed in 2% glutaraldehyde, analyzed using scanning electron micros-
copy and the surface area coated with biofllm quantitatively assessed.
Blood samples were taken at the time of insertion and removal of
catheters and analyzed for routine biochemistry, acute phase response and
hematology. Blood flow rates during each dialysis were recorded, as were
any complications such as catheter blockage or infection. MPC:LM coated
catheters were well-tolerated with no adverse features over conventional
catheters. No significant difference was found between groups for any of
the measured variables. However, the duration that the catheters re-
mained in situ was short, and complications related to biofilm deposition
may not be seen early. Larger patient numbers and longer duration of
catheter placement should enable better evaluation of the advantages of
coating hemodialysis catheters with MPC:LM.
Use of catheter brushes to diagnose internal luminal colonization of
hemodialysis catheters. ID. Dittmer, D. Sharp, A.J. Williams, CAM.
McNulty, and R.A. Banks, Renal Unit, Gloucestershire Royal Hospital,
Gloucester, England, United Kingdom. Central venous catheters are regu-
larly used for vascular access in patients with renal failure requiring
hemodialysis. We have previously shown that 95% of these catheters
become colonized with bacteria on their internal luminal surfaces. A total
of 75% are associated with peripheral bacteremia during dialysis that can
result in clinically relevant sepsis, including life-threatening metastatie
sepsis. The gold standard method for detecting colonization and catheter
associated sepsis is differential quantitative blood cultures. This method
involves culturing blood drawn from the catheter ports and peripheral
venepuncture. The laboratory processing of these specimens is laborious
and expensive. Long, narrow brushes (FAS Endoluminal Brush) have
recently become available for obtaining "swabs" of the internal lumen of
central venous catheters. This is the first evaluation of these brushes in the
dialysis situation. Swabs and quantitative blood cultures were taken from
both ports of the catheters of 6 patients. The blood cultures were
processed in the standard manner. Swabs were rolled on agar plates for
culture. Four samples had no growth by both blood and brush culture. Six
samples had positive cultures by both techniques. The organisms identified
by blood culture were identical to those isolated by brush culture. In one
case a positive culture was obtained by brushing while no blood could be
aspirated from the catheter port. In a further case the brushing was culture
negative hut an organism was isolated from the blood culture at a
concentration of less than 5 colony forming units per ml of blood. There
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were no complications associated with the brushings. This preliminary
study shows that catheter brushes may be an accurate, reliable and rapid
method of diagnosing central venous hemodialysis catheter colonization.
Temporary venous access for first dialysis is common, undesirable and
usually avoidable. A.M.S. Chesser and L.R.I. Baker, Department of Ne-
phrology, St. Bartholomew's Hospital, London, England. Late referral to a
renal unit for patients with end-stage renal failure is associated with
increased morbidity and mortality. An increased mortality has also been
described when emergency first dialysis is required via temporary venous
access, irrespective of whether the patient has received prior nephrological
follow-up. Despite this, we have found that many patients are still referred
to a renal unit too late to avoid emergency first dialysis (see table), and a
significant number (19.7%) require emergency first dialysis despite having
been under nephrological follow-up for more than three months. The
mortality in the first 90 days following first dialysis is significantly greater
in all those groups requiring emergency first dialysis.
Temporacy access required for first dialysis
Permanent More than Late referral
Eventual preferred access in Situ 3 months prior to renal unit
modality of dialysis at time of nephrology by referring
treatment first dialysis follow-up doctor
Hemodialysis 8 (0) 17 (0) 27 (4)
CAPD 43(1) 18(4) 20(1)
Total 51 (1) 35 (4) 47(5)
Eventual preferred
Patient decided
late on modality
modality of dialysis Late presentation of dialysis
treatment to medical profession treatment
Hemodialysis 24 (13) 6 (1)
CAPD 13 (2) 2 (0)
Total 37(15) 8(1)
Numbers of patients requiring temporary venous access for first dialysis
(90 day mortality figures are in brackets).
We conclude that nephrologists are often too slow to institute appropriate
planning for first dialyses, and referring doctors are often still too late in
referring their patients with chronic renal failure to a renal unit.
Transfer from pediatric to adult renal unit: Survey and strategy. AR.
Watson and D. Phillips, Children and Young Peoples Kidney Unit, City
Hospital, Nottingham, England, United Kingdom. The transfer of young
people with chronic illness from pediatric to adult units can be difficult for
all concerned. There is little information and discussion on the factors
involved in the timing and process of transfer. A questionnaire survey
dealing with aspects of the process was completed by 43 pediatric
nephrologists (23 from the USA) and 18 adult nephrologists (all from the
UK). Seventy-five percent of the pediatric units were located in a separate
children's hospital and only one third of the adult nephrologists were
based in the same hospital as the pediatric unit. Respondents were asked
to rank the importance of factors to be taken into account when
considering the timing of transfer to the adult unit. Sixty-seven percent of
pediatric nephrologists and 77% of adult nephrologists rated maturity as
the top factor, followed by patient wishes and age. Few nephrologists
would quote a specific age for transfer, with some patients being cared for
in pediatric units until they are in their twenties. Factors mentioned for
prolonged follow up in the pediatric unit included the need for other
sub-specialty follow-up or the inability to offer the same treatment
modality in the adult unit; for example, 5/43 pediatric units and 4/18 adult
units mentioned the lack of automated peritoneal dialysis at home as
being a factor. Five of 43 pediatric units also mentioned the lack of
psychosocial support in the adult Unit. Liaison visits by the young person
to the adult unit seem to be encouraged but there is no set pattern. Many
pediatric units favour a liaison visit by the patient accompanied by a nurse
or social worker. Only 4/43 pediatric Units held a joint clinic in conjunction
with adult colleagues, whereas 2 adult nephrologists share joint clinics with
pediatricians and 5 thought it was a good idea. It would appear that there
are problems to be addressed on both sides. Young people in the pediatric
unit need to be actively prepared for transfer to the adult unit and possibly
weaned off the very close multi-disciplinary support many enjoy. Transfer
to the adult unit needs to be more formalized and there may be problems
with "level transfer,' especially with automated peritoneal dialysis. Better
liaison and discussion between pediatric and adult units is necessary, and
the experience of other sub-specialties transferring young people with
chronic illness needs to be shared.
Vascular co-morbidity in patients with atheromatous renovascular
disease (RVD). P. MacDowall, P.A. Kaira, S. Cain, D.J. O'Donoghue, S.
Waldelc, I. Lang, and H. Mamtora, Department of Renal Medicine, Hope
Hospita4 University of Manchester, Manchester, England, United Kingdom.
It is well recognized that atheromatous renal artery stenosis (RAS) is
strongly associated with more generalized vascular pathology, particularly
peripheral vascular disease. Three hundred and seventy-two patients with
suspected RVD underwent angiography in this unit between 1986 and
1993; 115 patients with RAS were identified. Data of clinical characteris-
tics were available for analysis in 95 of these latter cases. The mean age of
the population was 62.9 years (27—88 years), male: female ratio was 1:1.1
and 60% were smokers. Significant RVD (RAS > 50% or occlusion) were
present in 80%. The mortality of this group was 36.8% to Jan. 1996.
Comparison was made between those patients with unilateral RAS and
those with bilateral disease for manifestations of generalized atheroma.
The findings are shown below, and the numbers are % of patients in each
group.
Unilateral
stenosis
N=63
Bilateral
stenosis
N=32
Total number
N=95
Atheroma distal 36.5% 56.3% 43.2%
aorta
Aortic aneurysm 12.6 21.9 15.8
CVA 7.9 9.4 8.4
TIA 9.6 6.3 8.4
Myocardial infarction 4.8* 18.8a 9.5
Angina 14.3 25.0 17.8
Cardiac failure 14.3 15.6 14.7
Claudication 27.0 31.3 28.4
Vascular bruits 35.4 31.3 34.7
ap = < 0.05
The occurrence of symptomatic peripheral vascular disease, renal or
femoral vascular bruits and of cerebrovascular disease was similar in the
two groups. There was a statistically higher incidence of MI in those
patients with bilateral RVD, but this finding was not reflected by an
increased mortality. Severe aortic atheroma was also more common in the
group with bilateral RVD, and may be a marker of severity and extent of
RAS.
Cardiovascular events on dialysis: A prospective analysis of lipoprotein
(a) [Lp(a)] and other risk factors. M. Misra, D.A. Reaveley, M Seed, and
E.A. Brown, Departments of Renal Medicine and Chemical Pathology,
Charing Cross Hospital, London, England, United Kingdom. Lp(a) is an
independent cardiovascular risk factor in the general population. We have
prospectively examined the association between Lp(a) levels and risk of
future clinical cardiovascular events in patients with ESRF, who are about
to start dialysis. Lp(a) was measured by ELISA and baseline cardiovas-
cular risk assessment was performed for 95 consecutive patients with
ESRF. The relation between future cardiovascular events (using defined
criteria) and baseline Lp(a) was studied over a mean follow-up of 25.6 (1
to 38) months. Median Lp(a) was 27.3 mg/liter in patients and 10.3
mg/liter in controls (P = <0.001). Median Lp(a) levels on entry, though
higher in patients with cardiovascular disease (414 mg/liter), were not
significantly different from those without the disease (340 mg/liter, P =
NS). Baseline median Lp(a) levels were significantly higher in those with
cerebrovascular disease (698 mg/liter), than in those without the disease
(334 mg/liter, P = 0.003). Baseline Lp(a) was only correlated to pre-
existing cerebrovascular disease (P = 0.005), but not to pre-existing
ischemic heart disease (IHD) or peripheral vascular disease (PVD).
Median serum Lp(a) was higher in patients who had events (426 mg/liter)
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than in those who did not have events (350 mg/liter), but this was not
significant. Stepwise multiple logistic regression analysis revealed that
serum Lp(a) at start was not an independent risk factor for future
cardiovascular events. However, low albumin (P = 0.013), diabetes
mellitus (P = 0.012) and hemoglobin (P = 0.032) were found to be
independent risk factors. When data for prevalence of IHD (N 65) and
PVD (N = 64) was included, previous clinical events due to IHD became
significant as a risk factor (P = 0.015), unlike pre-existing PVD (P =
0.081). These data suggest that elevated Lp(a) levels are not an indepen-
dent risk factor for predicting future cardiovascular events in patients on
dialysis.
Magnetic resonance angiography as a screening test for atheromatous
renal artery stenosis. P. Donohoe, T Doyle, D. Goldsmith, A. King, J. C.
Kingswood, M. Stewart, and P. Sharpstone, Renal Unit, and Department of
Diagnostic Imaging, Royal Sussex County Hospital, Brighton, England,
United Kingdom. Magnetic resonance angiography (MRA) is now a first
line screening test for atheromatous renal artery stenosis (ARAS), and has
benefits over standard arteriography (SA) in that it is completely non-
invasive. A prospective comparative study of MRA versus SA was
performed in 21 patients with clinical suspicion of ARAS, over a 15 month
period. MRA and SA were performed, in most cases, within the same 3
months. SA was performed as an aortic flush, with or without selective
renal studies, via the femoral artery. Intravenous digital subtraction
angiography was performed (instead of a flush procedure) in 2 patients
with severe femoral atheroma. MRA was performed on a Phillips 0.5
Tesla T5 release III, using Ti gradient echo, and 3D phase contrast. One
radiologist reported the MRA's, five reported the SA's; all were blinded to
the results of other scans. MRA correctly identified the number of renal
arteries in 20 of the 21 patients. Using SA as the "gold standard,' MRA
had a sensitivity of 92% and a specificity of 62.5%, with regard to detection
of ARAS. MRA had a positive predictive value of 62%, but a negative
predictive value of only 9%. In 2 cases, MRA correctly identified ARAS
lesions that had not been noted on reporting of SA (but evident on
re-examining of the films). Statistical analysis showed a chi-squared value
of 9.997, indicating excellent statistical agreement between the 2 tests. In
4 patients, MRA overestimated the severity of ARAS due to a tortuous
renal artery. Only 3 patients were excluded from the trial, as a conse-
quence of having standard MRA exclusion criteria. MRA was well
tolerated by all patients. We conclude that MRA is a useful, non-invasive
screening test for ARAS, demonstrating sensitivity and specificity which
are in general comparable to that reported with captopril renography
(85% and 72%, respectively) and Doppler ultrasound (31 to 91% and
73%), apart from a very low negative predictive value. We will continue to
use MRA as a first line screening test for patients with possible ARAS.
Neutrophil FCyRIIA-polymorphism as heritable risk factors for ANCA
positive vasculitis. W. Y. Tse, K. Quibell, D.S. Kumararatne, C.0.S. Savage,
and D. Ado, Department of Nephrology, Queen Elizabeth Medical Centre
and Department of Immunology, University of Birmingham, Birmingham,
England, United Kingdom. TNFa-primed neutrophils can he activated by
ANCA to produce reactive oxygen species (ROS) by cross-linking surface
ANCA antigens with neutrophil FeyRIla receptors. These FcyRIIa
receptors exhibit a genetically determined polymorphism (H/H131,
R/Rl31, II/R131) resulting in heterogeneity of affinity for human IgG
subclasses. Neutrophils homozygous for the H/H131 allotype bind more
efficiently to IgG3 than the R/R13i allotype and is the only human FcyR
which binds IgG2. Although ANCA activity can be found in all IgG
subclasses, there is a relative increase of IgG3 in acute disease, with an
increase of IgG2 in remission. These observations lead us to hypothesize
that FcyRlla polymorphism may play a role in determining disease
susceptibility or expression in ANCA-associated vasculitides due to dif-
ferential TgG binding and activation. The FcyRIIa allelic frequencies were
determined in 91 patients with ANCA-positive vaseulitis (45 Wegener's
granulomatosis, 41 microscopic polyangiitis, 4 polyarteritis nodosa, 1
Churg Strauss syndrome; 68 cANCA, 23 pANCA) and 100 healthy
controls. FcyRlIa allotype was detected by Southern blotting using allele
specific oligonuclcotidc probes end labeled with 32P-y-ATP, after PCR
amplification of genomic FcyRIla DNA; and also by quantitative flow
cytometry. We found no overall difference in the allotypic frequencies
between vasculitis patients and controls (x2 = 1.80, P - 0.43). However,
there was a significant increase in H/Hl31 allotype frequency in patients
with pANCA vasculitis (odds ratio 3.28, 95% CI 1.20 to 8.99, P = 0.02) but
not in patients with cANCA vasculitis, compared with controls. These
preliminary data suggest that individuals with the homozygous FCy
RIIa-H/H131 allotype are at increased risk of developing pANCA-positive
systemic vasculitis. It is possible that the increased reactivity of this
receptor for IgG3/IgG2 could lead to a greater production of ROS after
binding by ANCA. This preliminary data suggest that individuals with the
homozygous FcyRIIa-H/H131 allotype are at increased risk of developing
ANCA-positive systemic vasculitis. It is possible that the increased reac-
tivity of this receptor for IgG3/IgG2 eould lead to a greater production of
ROS after binding by ANCA.
Genetic analysis of susceptibility to EAG in Wistar Kyoto rats. .1.
Reynolds, V.0. Newman, U. Aitman, Di. Evans, and CD. Pusey, Renal
Unit, Department of Medicine and Molecular Medicine Group, CS, Royal
Postgraduate Medical School and Department of Histopathology, ICSM St
Mary's Hospital, London, England, United Kingdom. We have previously
shown that experimental autoimmune glomerulonephritis (EAG) can be
induced in Wistar Kyoto (WKY) rats by an i.m. injection of collagenase-
solubilized rat GBM in FCA. This resulted in circulating and deposited
anti-GBM antibodies, accompanied by albuminuria, deposits of fibrin in
the glomeruli and focal necrotizing glomerulonephritis with crescent
formation. We have also shown that Lewis (LEW) rats immunized with
the same antigen developed similar levels of circulating anti-GBM anti-
bodies, but minimal glomerular deposits, and no albuminuria or histolog-
ical evidence of nephritis. This work demonstrates that WKY rats are
susceptible to EAG, while LEW rats are resistant. To investigate the
genetic base of susceptibility to EAG, we examined the response of both
F1(WKY X LEW) and backcross (BC1)(WKY X Fl) rats to immuniza-
tion with rat GBM in FCA. Fl animals developed circulating and
deposited anti-GBM antibodies, hut no albuminuria or glomerular abnor-
malities. However, BCI animals showed a range of responses to the GBM
antigen. Thirty-one percent of BC1 rats developed severe crescentic
glomerulonephritis, 31% developed mild proliferative glomerulonephritis,
and 38% showed no histological evidence of nephritis. The severity of the
nephritis correlated with the amount of albuminuria (r = 0.93, P < 0.001).
All BC1 animals developed circulating and deposited anti-GBM antibod-
ies. The Table shows the number of rats from each generation with
glomerulonephritis.
Group N
Albuminuria
0—10 mg 10—100 mg >100 mg
WKY
LEW
Fl
BC1
5
5
12
13
0
5
12
5
0
0
0
4
5
0
0
4
Group
Abnormal glomeruli
0—10% 10—50% 50—100%
WKY
LEW
Fl
BC1
0
5
12
5
0
0
0
4
5
0
0
4
These results indicate that susceptibility to EAG is inherited as a recessive
trait in this strain combination, and demonstrate the feasibility of mapping
the underlying genes by genetic linkage analysis. Mapping studies are now
underway using PCR-analyzed microsatellites in segregating BC1 progeny.
Localization of a gene for autosomal dominant inherited hemolytic
uremic syndrome to chromosome lq. P. Wanvicker, J.A. Goodship, Y.
Pirson, A. Nicholls, P. Tumpenny, and T H.J. Goodship, Department of
Medicine and Department of Human Genetics, Newcastle upon Tyne,
England, United Kingdom; Renal Unit, Cliniques Universitaires St Luc,
Brussels; Renal Unit and Clinical Genetic,c Service, Royal Devon and Exeter
Hospital, Devon, England, United Kingdom. Non infective hemolytic ure-
mic syndrome (HUS) usually affects adults and often carries a poor
prognosis. An important although rare subgroup comprises the familial
form of the disease. Approximately 20 families have been reported in the
literature, with both a dominant and recessive form of inheritance. We
Abstracts 269
have carried Out a linkage study in 3 families with the inherited form of the
disorder using microsatellite polymorphisms in the region of the potential
candidate genes. A 26 cM cluster of markers located at 1q32, gave a
significant lod score (Z max. = 3.95, 0 = 0) in the three families. Using
2 novel polymorphisms we have identified in the factor H gene, we have
been able to confirm that it maps within our region of linkage. A role for
complement in the pathogcnesis of HUS has been suspected for several
years, and hypocomplementemia, reflecting activation of the alternative
pathway, is often noted in case reports. Factor H, a major plasma protein,
occupies a central role in the regulation of this pathway. In summary, we
describe genetic linkage between inherited HUS and an area of chromo-
some 1, which we have shown to contain the gene for factor H and related
proteins.
LDL particle size—A vascular risk factor in proteinuria? Cf. Deighan,
Mi. Caslake, M. McConnell, J.M. Boulton-Jones, and C.J. Packard, Renal
Unit and Department of Pathological Biochemistry, Glasgow Royal infirmary
University NHS Tmst, Glasgow, Scotland, United Kingdom. Heavy protein-
uria is associated with marked abnormalities of lipoprotein metabolism
and increased risk of atherogenesis. LDL exhibits heterogeneity with
small, dense LDL III particles being more atherogenic. The aim of this
study was to investigate LDL subfractions in patients with heavy protein-
uria. LDL subfractions were measured by density gradient ultracentrifu-
gation in 12 patients with 10 glomerular disease and 24 hour albuminuria
>2.5 g, along with VLDL subfractions and post-heparin lipases. These
were compared to 23 age- and sex-matched normolipemic controls
randomly extracted from the database in the Department of Pathological
Biochemistry. Total LDL concentrations were similar (patients 285 28
mg/dl, control 334 18 mg/dl, P = 0.1). Each subfraction, however, was
significantly different with LDL I and LDL II being lower in the
proteinuric group (32 7 mg/dl vs. 62 5 mg/dl, P = 0.011 and 121 23
mg/dl vs. 193 16 mg/dl, P = 0.041), whereas atherogenic LDL III (small
dense) was higher in the proteinuric group (135 18 mg/dl vs. 75 15
mg/dl, P = 0.0016). Total VLDL concentrations and VLDL suhfractions
were all increased in the patients with proteinuria (VLDL total 339 80
mg/dl vs. 103 13 mg/dl, P = 0.014, VI 192 51 mgldl vs. 58 9 mgldl
P = 0.028, V2 147 34 mg/dl vs. 45 5 mg/dl P = 0.049). Post-heparin
hepatic and lipoprotein lipasc levels were similar. These findings suggest
that atherogenic LDL is significantly more common in patients with heavy
proteinuria. Since small dense LDL has a lower affinity for the LDL
receptor, the altered nature of the lipoprotein in proteinuria may decrease
its clearance by the receptor mediated pathway and contribute to the
reduced clearance of LDL observed in this population. This may contrib-
ute to the accelerated vascular disease found in patients with heavy
proteinuria.
Targeted prescription dialysis delivery and quality of life—A prospec-
tive controlled intervention trial. W.D. Plant, KJ. Craig, S. W. Walker, R.J.
Prescott, and Ri. Winney, Department of Renal Medicine and Clinical
Biochemistry, Royal Infirmary of Edinburgh NHS Tmst; Medical Statistics
Unit, Edinburgh University, Edinburgh, Scotland, United Kingdom. Study
objective: To evaluate if introduction of an operational strategy to deliver
targeted prescription dialysis leads to improved patient quality of life
(Q0L) or impacts upon nutritional status, morbidity and survival. Study
design: Prospective controlled intervention trial over 12 months. The
Control (C) group was provided by minimization of the variance of
imbalance for selected levels of 24 sociodemographic, co-morbid medical,
treatment and QoL variables. Dialysis prescription was adjusted proac-
tively in the intervention (I) group to attempt delivery of a target dialysis
dose [Kt/V of 1.2 per treatment for hemodialysis and total weekly
creatinine clearance (WCC) of 50 I/week/i .73 m2 for peritoneal dialysis].
Changes from baseline in the McMaster Health Index Questionnaire
score, the Hospital Anxiety and Depression Scale, the Karnofsky Scale,
and serum albumin levels were assessed. Number of days of hospitaliza-
tion was used as a surrogate measure of intercurrent morbidity. The study
has 80% power at the 5% level to detect significant changes in most
variables of interest. Subjects: One hundred fourteen clinically stable
ESRD patients, treated by dialysis for more than 6 months, entered the
study. Eighty-two (72%) remained on dialysis for 1 year. Fifty-seven (50%)
completed all stages of the protocol. Results: Eighteen percent of patients
died. Nine percent were transplanted. The proportion achieving target
dialysis dose rose from 30% to 43% in group (1), and fell from 47% to
27% in group (C). Median (IQR) inpatient days were 6(28) versus 5(23),
respectively. Mean (95% CI) changes in serum albumin were +0.80 (—0.2,
+ 1.9) versus —1.0 (—2.5, +0.5) g/liter respectively. Changes from baseline
in all QoL scores were modest and did not differ between groups. No
change from baseline in any of these outcomes of interest achieved
statistical significance. Conclusion: With the operational strategy em-
ployed in this study, an attempt to introduce target prescription dialysis
delivery did not lead to any improvement in a number of important
outcome variables after 1 year.
Lupus nephritis, renal dysfunction and associated anticardiolipin
antibody and intraglomerular thrombi. S. Bhandari, AM. Brownjohn, J.H.
Tumey, P. Hamden, Renal Unit, Leeds General Infirmary, Leeds, England,
United Kingdom. The presence of intraglomerular capillary thrombi (ICT)
has been described in association with anti-cardiolipin (ACA) positivity in
patients with systemic lupus erythematosis (SLE). However, controversy
remains as to its significance in progression of renal disease. We per-
formed a retrospective study of 50 patients with SLE (10 male, 40 female),
mean age 37 years, and clinically evident nephritis confirmed by renal
biopsy. Analysis of biopsies revealed that the percentage of sclerosis,
crescent formation and necrosed glomeruli were greater in both speci-
mens positive for thrombi and from patients with positive serum ACA. An
increase in serum anti-DNA and ANA antibodies and a reduction in C3
and C4 were significant in ACA+ patients, with a strong relationship to
disease activity when compared with changes in ACA negative patients
(P < 0.05 in all cases). No significant difference occurred when patients
were separated according to the presence or absence of thrombi. The
presence of ICT correlated with positivity for ACA (P = 0.0015), ACA
positivity was associated with renal dysfunction at presentation (P =
0.042), while the presence of ICT was significant at conclusion (P = 0.007).
In patients with both thrombi and positivity for ACA, renal progression
was worse (P = 0.0054). Hypertension and nephrotic range proteinuria
were more common in thrombi positive or ACA positive biopsies.
Twenty-one thrombotic episodes occurred in 14 patients of which 13 were
ACA+. In conclusion, ACA is a strong predictor of the presence of
intraglomerular thrombi in SLE patients with renal involvement. Thrombi
presence indicates a worse long-term renal outcome. ACA positivity is a
strong predictor of vascular thrombotic complications. In patients with
SLE, ACA status and biopsy screening for the intraglomerular thrombi is
important.
An intact tissue RAS is required for the transition to malignant
hypertension. C. Whitworth, H. Montgomery, L. Kieman, S. Fleming, T.
Ungar, P. Gohlke, J. McEwan, J. Mullins, Leicester University, Leicester, and
UCLMS, London, England, United Kingdom; Department of Pathology,
University of Edinburgh and Centre for Genome Research, Edinburgh,
Scotland, United Kingdom; and Universität zu Kid. An intrinsic role for the
RAS in the genesis of MH in transgenic Ren-2 rats has been suggested by
previous studies, but it is not known whether this is independent of direct
pressure. The ACE inhibitor, Ramipril, was administered to male Ren-2
heterozygotes from 28 days of age at a dose of 5 rg/kg/day. SBP was
measured by tail cuff plethysmography in treated (N 24) and untreated
controls (N 40) from 30 to 120 days of age (x3/wk). SBP did not differ
in the treatment period, reaching means of —250mm Hg by 50 days of age
in both groups. Sixty-three (25/40) untreated rats died with MH (con-
firmed by light microscopy) compared with only 4% (1/24) treated rats.
Histological examination showed medial hyperplasia, hut no fibrinoid
necrosis in the treatment group. Features of chronic hypertensive renal
damage were common in untreated survivors, but less frequent or severe
in the ACE! treated group. Tissue ACE activity was significantly reduced
in resistance vessels, inyocardium and kidney, in treated rats while in Vitro
plasma ACE activity rose by 52%. In conclusion, ACE inhibition at a
non-hypotensive dose protected rats from developing MH and reduced
the severity of chronic renal damage, suggesting that an intact tissue RAS
may be involved in hypertension-induced renal injury.
Relationship between plasma Leptin, fat and diet in chronic renal
failure. GA. Young, G. Woodrow, S. Kendall, B. Oldroyd, L. Tompkins, J.H.
Turney, and A.M. Brownjohn, Renal Research Unit, General Infirinaiy,
Leeds, England, United Kingdom. Loss of appetite contributes to malnu-
trition in chronic renal failure. Recent studies suggest that Leptin, the ob
gene protein, has an endocrine function for lowering food intake and
adiposity. Increased plasma concentrations in obesity may be ineffective
due to resistance or reduced brain uptake. We have compared plasma
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leptin with body composition, measured by DEXA and other techniques,
in subjects grouped as undialyzed CRF (N = 23), PD (24), HD (22) and
controls (24). Plasma leptin was higher for PD patients (35 ng/ml vs. 13.8
ng/ml in controls), although most had a similar percentage of fat to
controls. Leptin was not significantly increased for HD and CRF groups,
but both had less fat than controls. However, leptin was more than fivefold
greater for some individuals in all patient groups. Higher leptin in females
was due to higher body fat. Leptin was highly correlated with total, arm,
leg and all other fat measurements, for example, Rs for leptin vs. % total
fat was: CRF 0.88, PD 0.81, HD 0.93 and controls 0.83 (P < 0.0001 for all).
Lean tissue was lower in dialyzed patients than in controls. Leptin
correlated inversely with total lean tissue/height2, that is, Rs = —0.38 (N =
69). Dietary intake was assessed in dialysed patients and leptin correlated
inversely with energy Rs =
—0.47, and protein intake, Rs = —0.54 (P <
0.001 for both). Leptin also correlated with cholesterol, C3, triglycerides
and insulin. In dialyzed and non-dialyzed patients, leptin is higher than for
normals with comparable body fat and probably contributes to loss of
appetite and malnutrition. The close association with fat indicates its value
as a marker of body composition.
Effect of nitric oxide synthase (NOS) inhibition on renal function and
hemodynamics in endotoxemia. C.G.M Millar, C. Thiemermann, and J.R.
Vane, The William Harvey Research Institute, St Bartholomew's and the
Royal London School of Medicine and Dentistry, London, England, United
Kingdom. An overproduction of nitric oxide (NO) contributes to the
hemodynamic alterations and organ dysfunction in septic shock. NOS
inhibition improves hypotension and restores vascular responsiveness to
vasopressor agents, but regional perfusion may be impaired. We have
investigated the effect of the non-selective NOS inhibitor N°-methyl-L-
arginine (L-NMMA) on systemic and renal hemodynamics and renal
function in a rat model of endotoxemia induced by lipopolysaccharide
(LPS, 1 mg/kg over 30 mm). Hemodynamic parameters included mean
arterial blood pressure (MAP), renal blood flow (RBF) and cortical (C
flux) and medullasy (M flux) laser Doppler flow. Clearance of 3H-inulin
(C,) was used as an index of glomerular filtration rate. All animals
received NACI 0.9% at 3 ml/hr. Following a control period, vehicle (N =
6) or L-NMMA (50 g/kg/min, N = 7) was infused.
Post-LPS
Control 1—2 hr
MAP mm Hg LPS + Vehicle
L-NMMA
112± 3
110± 2
102± 6
112
control Vehicle
L-NMMA
100
100
44 765 4
C flux % control Vehicle
L-NMMA
100
100
81 3
73 3
M flux % control Vehicle
L-NMMA
100
100
78 680 8
Post-LPS
3—4 hr
Post-LPS
5—6 hr
MAP mm Hg 97 6"
108±5
91 4"
103±4
Ci,, % control 47 3
69±Sb
44 2
75÷61,
Cflux %control 79±4
62±4k
75±6
69±4
M flux % control 77 9
61±7
70 13
54±6
a P < 0.05 vs. control
< 0.05 vs. vehicle
Following LPS, MAP was maintained until it fell at 4 hr. L-NMMA
prevented this late fall. C1,, fell immediately after LPS and remained
reduced for 6 hr. In rats receiving L-NMMA, C,, recovered to 75%
baseline by 6 hr. RBF did not change significantly. The reduction in C flux
was enhanced by L-NMMA. In this model, M flux fell in both groups.
Thus, L-NMMA (at a dose that does not affect total RBF) improves renal
function in endotoxemia.
Visceral glomerular epithelial cell proliferation in experimental and
human membranous nephropathy. S. Haiper, E. Bailey, F. Baker, P.N.
Furness, D.J. Salant, and J. Feehally, Departments of Nephrology and
Pathology, Leicester General Hospital, Leicester, and Richard Bright Renal
Unit, Southmead Hospital, Bristol, England, United Kingdom; and Renal
Section, Boston University Medical Centre, Boston, Massachusetts, USA.
Human membranous nephropathy (MN) is not a proliferative pattern of
glomerular disease. However, visceral glomerular epithelial cell (vGEC)
proliferation has been claimed as a feature of passive Heymann nephritis
(PHN, a model of MN); these studies used proliferating cell nuclear
antigen, a non-specific marker of cellular proliferation. We have used the
non-isotopic in Situ hybridization demonstration of histone mRNA, an
S-phase specific marker, to study glomerular cell proliferation in PHN and
MN. PHN was induced in 24 Sprague-Dawley rats by tail vein 0.75 ml
injection of sheep antibody to Fx1A on days 1 and 2. Eight controls
received saline or sheep serum, and 12 animals (PHN 8, Saline = 2,
Serum 2) were sacrificed on day 5, the same number on day 10.
Twenty-four hour urinary protein loss was quantified on day 0 and prior to
sacrifice. Renal biopsies from 10 cases with MN and proteinuria, and 10
age- and sex-matched controls were also studied. Controls had normal
biopsies and no proteinuria. Twenty-four hour PHN animals had heavy
proteinuria by day 10 and demonstrated significantly more histone mRNA
positive cells per glomerulus by day 5 compared to controls (0.53 0.09
vs. 0.195 0.045, P < 0.01). There was a significant increase in histone
mRNA positive glomerular cells in patients with MN compared to controls
(0.24 0.07 vs. 0.04 0.018 positive cells per glomerular cross-sectional
area respectively, P < 0.03). In both PHN and MN studies, cells at the
periphery of the glomerular tuft with typical morphology of vGECs were
histone mRNA positive. Therefore, vGEC proliferation is a feature of
PHN soon after the onset of complement-mediated vGEC injury. In
addition, a significant increase in S-phase cells was seen in MN in a similar
distribution to that in PHN. These data call into question the notion that
mature vGECs are terminally differentiated and incapable of cell division.
Effects of angiotensin-converting enzyme inhibition on glomerular
volume in experimental diabetes. P. Mackin, KE. White, R. W. Bilous, and
SM. Marshall, Department of Medicine, The Medical School, University of
Newcastle upon Tyne, Newcastle upon Tyne, England, United Kingdom.
Experimental diabetes is associated with renal enlargement and hyper-
function. Total glomerular volume is increased by 30% after only 4 days of
streptozotocin diabetes. Altered renal hemodynamics, resulting in raised
intergiomerular pressure, may play a role in the initial renal enlargement
observed in diabetes. We investigated this hypothesis by studying the
effects of trandolapril (0.01 mg kg1 day') on renal morphology, in the
first week of experimental diabetes. This dose is sufficient to reduce tissue
ACE activity by 86%, with only a minimal effect on systemic blood
pressure. Five groups of male Wistar rats were studied: C (control); CTr
(control + trandolapril); D (diabetic); DTr (diabetic + trandolapril) and
DI (diabetic + insulin). Diabetic animals had marked hyperglycaemia
throughout the study period (day 7 blood glucose values (mean so) D =
22.2 3.4 mmol I; DTr = 24.1 3.7 mmol j_1, P = NS), and blood
glucose levels were similar in groups C, CTr and DI(C = 5.3 1.0 mmol
j_1; CTr = 4.8 0.4 mmol 1'; DI = 5.6 1.6 mmol I_I, P = NS).
Animals were sacrificed on day 7. Kidney volume (C = 0.868 0.061
mm3; D = 1.169 0.059 g; DTR = 1.059 0.114 g) and weight (C =
0.902 0.48 g; D = 1.202 0.097 g; DTr = 1.15 0.119 g) was increased
in groups D and DTr (P < 0.01 vs. other groups). However, total
glomerular volume was increased in group D only (37.3 4.2 mm3) and
was similar in all other groups (C = 28.0 2.3 mm3; DI 27.0 2.4 mm3;
DTr = 26.7 7.6 mm3, P < 0.05 vs. D). These data demonstrate that
amelioration of intraglomerular pressure by ACE inhibition does not
prevent the increase in whole kidney size, but has a salutary effect on
glomerular enlargement, suggesting that differential growth is occurring
within the kidney.
Progression of diabetic nephropathy (DN)—Is diurnal BP rhythm
more important than BP level? C.KT. Farmer, J. Cox, P. Dallyn, P.
Shaipstone, J. C. Kingswood, J. Quinn, and D.J.A. Goldsmith, TraJJbrd
Department of Renal Medicine, Royal Sussex County Hospital, Eastern Road,
Brighton, England, United Kingdom. Factors that are implicated in renal
functional decline in DN include diabetic control (HbAlc) and blood
pressure. In chronic renal failure and diabetes, abnormal diurnal BP is
commonly seen when ambulatory BP monitoring (ABPM) is performed;
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this is thought to be an additional risk for end-organ damage. We studied
26 patients with known DN and declining renal function, who underwent
38 ABPM recordings between 1990 and 1996, to assess the relative
contributions to progression of DN from: (a) overall BP levels; (b) diurnal
BP rhythm; and (c) diabetic control. Diurnal BP was defined as normal if
>/=10% fall in SBP at night (that is, 'Dipper"). Results are in the table
(Mann-Whitney U-test; P < 0.05):
Dippers Non-dippers P
Number 13 13
Age years 55.2 51.7 NS
SBP awake, mm Hg 144 152 NS
SBP sleep, mm Hg 126 144 <0.05
Creatinine pmol/liter 116 192 <0.05
24 hr protein g 2.7 3.5 NS
ZGFR mi/mm/yr —2.9 —7.9 <0.05
HbAlc % 7.4 8.5 NS
IDDM/NIDDM 3/10 4/9 NS
These results demonstrate a relationship between BP and rate of renal
functional decline in DN. There is a profound effect of dipping/non-
dipping status, which is at least as important as the BP level. Diabetic
control (HBA1c) is irrelevant, at least in this study. It may be that
non-dipping BP status is a marker for other adverse factors, possibly
autonomic dysfunction.
An epidemiological study of patients with renovascular disease in a
single center. P. Macdowel!, PA. Kalra, S. Cain, D.J. O'Donaghue, S.
Waldek, I. Laing, and H. Mamtora, Department of Renal Medicine, Hope
Hospital, University of Manchester, Manchester, England, United Kingdom.
Three hundred seventy-two angiographic studies for suspected RVD were
performed between 1986—1993 in this unit. One hundred thirteen patients
were found to have RVD. A retrospective analysis of the epidemiological
characteristics was performed in 95 patients where data were available.
Eighty percent had significant lesions (RAS > 50% or occlusion = RAO).
The mean age at time of investigation was 62.9 years (range 27—88 years),
male: female ratio was 1:1.1; 61.1% were smokers, 28.4% had peripheral
vascular disease, 45.3% had significant hypertension (systolic BP > 170
mm Hg, diastolic BP > 100), and 15.8% were diabetic. Nineteen patients
had RAS <50% (17 unilateral, 2 bilateral). The angiographic findings and
renal function of patients with significant RAS are shown below.
>50% RAO
Renal function 21
(R12L9)
23
(R13L1O)
Normal 7 2
Mild-Mod. 11 15
Severe 3 6
Bilateral stenosis
1< 50%
I > 50%
1 < 50% 1
1 RAO 2 > 50% 1
> 50%
RAO
Bilateral
RAO
Of the patients with anatomically insignificant stenosis, 12 had normal
renal function and 7 mild-moderate renal impairment (creatinine 120—450
trmol/liter). As can he seen, 8 patients had bilateral occlusion, and all of
these patients presented with dialysis-requiring renal failure. Twelve
others had severe renal failure (ereatinine  450 mol/liter), of whom 8
had unilateral occlusion. Mean follow-up was 50.5 months to 1/1/96 or to
death. Mortality was 36.8% during this period. This study highlights the
relationship of RVD with PVD, smoking and renal failure and indicates
the high mortality of these patients due to excess cardiovascular co-
morbidity. Of the 23 patients with significant bilateral RVD, 8 needed
RRT at presentation and 40% of the remainder progressed to ESRF over
a mean period of 46.5 months.
Down-regulation of the erythropoietin receptor in uremia. D.A. Allen,
IC. Macdougall, and MM. Yaqoob, Anthony Raine Research Laboratories,
St. Bartholomew's Hospital, and Department of Nephrology, King's College
Hospital, London, England, United Kingdom. Hyporesponsiveness to eiyth-
ropoietin (EPO) in uremic patients is well-documented, but the cellular
mechanism(s) remains to be elucidated. Previous studies have shown that
sera from uremie patients with or without inflammatory disease cause a
blunted bone marrow response to EPO in vitro. The aim of this pilot study
was to determine the level of EPO receptor (EPOR) expression in an
erythroid cell line, TFI, under normal and uremic conditions. TF1 cells
were maintained in RPMI-1640 medium containing 10% FCS. i0' cells/mi
were seeded in medium containing 1 U/mI EPO and either: (a) 10%
normal human serum; or (h) 10% uremic human serum for 48 hours at 37°
in 5% CO2 in air. Cells were then washed and lysed in RIPA buffer
containing protease inhibitors. After centrifugation at 15000g superna-
tants were removed and 10 g of protein was subjected to SDS-PAGE and
electroblotted onto nitrocellulose membrane. Membranes were blocked
overnight and immunoblotted with rabbit anti-human EPOR polycional
antibody (1:2000) followed by HRP-conjugated anti-rabbit lgO (1:3000).
Signals were detected using the Amersham-ECL system. Blots were
subjected to densitometric analysis and band density expressed as peak
area (pA) and % control pA. Control TF1 cells express a 46 kDa EPOR
protein, consistent with published data (pA 3937; 100%). Cells cultured
in 10% uremic serum expressed fewer EPOR when compared with
controls (pA = 1814; 46%). This preliminary data suggests that EPOR is
down-regulated by a factor(s) present in uremic serum. The effect of sera
from uremic patients who are resistant to EPO on EPOR expression
remains to be determined.
Increased vascular permeability factor (VPF) mRNA expression in
minimal change disease (MCD). Mi. Bottomley, P.E.C. Brenchley, N.J.A.
Webb, I.S.D. Roberts, J. Feehally, and S. Haiper, Renal Research Group, St
Mary's Hospital, Manchester and Department of Nephrolo,ry, Leicester
General Hospital, Leicester, England, United Kingdom. VPF is a disulphide
linked homodimer of 34 to 42 kDa with potent capillary enhancing
properties and has previously been implicated in the pathogenesis of the
heavy proteinuria associated with MCD. In situ hybridization (ISH) and
Unilateral stenosis
Urinary tissue factor levels in glomerulonephritis: A potential marker
of glomerular injury? BA. Lwaleed, P. Bass, M. Chisholm, and J.L.
Francis, University Department of Haematology and Department of Pathol-
o, Southampton University Hospitals, Southampton, England, United
Kingdom; and Hemostasis and Thrombosis Research Unit, Walt Thsney
Memorial Cancer institute at Florida Hospital, Altamonte Spring, Florida,
USA. Coagulation activation and fibrin deposition are common events in
human and experimental glomerulonephritis (ON). These phenomena
occur by multiple pathways, but local expression of tissue factor (TF) by
infiltrating monocytes/macrophages (mTF) and resident glomerular cells
may be involved. TF is found in the urine (uTF) where levels may mirror
glomerular activation. We have recently developed a highly standardized
assay for uTF. Using this assay, we measured uTF levels in controls
___________ ___________ _________
(healthy volunteers and patients with uncomplicated renal stones) and in
patients with immune complex (IC) ON and non-IC GN. The uTF level
was significantly higher in patients with ON compared to normals (P <
0.01) or renal stones (P < 0.05). uTF activity correlated with the Protein
Creatinine Index (PCI, r = 0.41, P < 0.001) and 7 patients with ON and
a PCI 0.1 g/mmol had elevated uTF levels. We then subdivided the ON
patients into two groups depending on the PCI: <0.2 g/mmol creatinine
__________ _________
(mild to moderate proteinuria, group I) and 0.2 g/mmol creatinine(heavy proteinuria, group II). Analysis of group I showed there was a
significant difference between normals and the tC (P < 0.01) and non-IC
(P < 0.05) groups. In group II, the IC group showed significantly higher
uTF level compared to normals (P < 0.001) and renal stones (P < 0.01).
A significant difference was also observed between non-IC and normals
(P < 0.01). When the ON groups were divided into broad WHO subtypes,
the significance level varied with the type of the ON. We conclude that
uTF levels are significantly raised in patients with ON, particularly in
heavy proteinuria. In addition the level of uTF may reflect the etio-
pathogenesis of ON.
Renal function 2
Normal 1
Mild-Mod.
Severe 0
7 11 4 8
1 1 0 0
5 8 3 0
1 2 1 AIIRRT
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immunohistochemical studies have shown VPF to be constitutively ex-
pressed by glomerular epithelial cells (GEC5) in the normal adult kidney.
Renal biopsies from 10 proteinuric adults with MCD were investigated for
VPF expression. All had normal renal function at the time of biopsy. Ten
age/sex matched non-proteinuric adults with normal renal function biop-
sled for microscopic hematuria acted as controls. All had normal biopsies
with no evidence of foot process effacement, electron dense deposits or
thin basement membrane at EM level. VPF mRNA expression was
investigated using non-isotopic ISH. mRNA for all four alternatively-
spliced VPF transcripts was detected using twelve 3Omer hapten labelled
oligonucleotide probes spanning the entire VPF sequence. Alkaline
phosphatase labeled Fab fragments to hapten and nitro blue tetrazoleum
substate were used for the final detection step. Biopsies, reviewed by a
single investigator blinded to the clinical histories, were scored according
to the number of cells expressing VPF mRNA per glomerulus. No
significant difference was detected in glomerular size between MCD and
control biopsies. VPF mRNA was only detected in GECs consistent with
the findings of other groups. The number of GECs expressing VPF per
glomerulus was significantly higher in MCD than control biopsies (P <
0.3). mRNA positive GECs were uniformly distributed within the glomer-
ulus in normal biopsies, though clustered at the peripheries in MCD
biopsies. There was no difference in glomerular histone mRNA expression
between the two groups (P = 0.03). Analysis of urinary protein data
revealed a significant correlation between 24-hour protein excretion at the
time of biopsy and the number of VPF mRNA positive cells per
glomerulus (r = 0.80, P = 0.01). Up-regulation of intrarenal VPF mRNA
may be central to the pathogenesis of proteinuria in MCD.
Altered 0-glycosylation of IgAl in Henoch Schönlein purpura is
restricted to subjects with nephritis. A. C. Allen, F. Willis, S.J. Harper, T.J.
Beattie, and .J. Feehally, Department of Nephrology, Leicester General
Hospita4 Leicester and Renal Unit, Royal Hospital for Sick Children,
Glasgow, Scotland, United Kingdom. We have previously described abnor-
mal 0-glycosylation of IgAl in IgA nephropathy (IgAN), detected by
increased binding of the lectins Vicia Villosa (VV) and HelL-c aspersa (HA).
Henoch SchOnlein purpura (HSP) is a systemic vasculitis with IgA
deposition in various sites, often including the kidney. The aims of this
study were to investigate whether the 0-glycosylation defect of IgAl seen
in IgAN is also found in HSP, and whether HSP patients without nephritis
display the same abnormality. Serum was obtained from children with
HSP with (N = 28) and without (N = 22) nephritis, and from adults with
HSP nephritis (N = 33), IgAN (N = 20), and membranous nephropathy
(MN) (N = 8). Age- and sex-matched controls for each group were also
recruited. Ammonium sulphate precipitates were prepared from the sera
and applied to anti-IgA coated immunoplates. Biotinylated VV or HA
lectins were applied and their binding to the 0-glycans detected with
peroxidase-avidin and OPD substrate. The results were expressed as OD
at 492 nm. In both IgAN and HSP in adults, IgA showed raised lectin
binding as compared to controls (IgAN 0.56 0.04 vs. 0.39 0.03, P =
0.001; HSP 0.53 0.02 vs. 0.48 0.02), but in MN, lectin binding was
normal (0.45 0.06 vs. 0.42 0.06, P = NS). Serum IgA from children
with HSP and nephritis also showed significantly higher lectin binding than
matched controls (0.53 0.04 vs. 0.41 0.01, P < 0.004). However, IgA
from children with HSP but without nephritis had significantly lower
binding than those with nephritis (0.41 0.02 vs. 0.53 0.04, P < 0.005),
and did not differ from controls. These data show abnormal 0-glycosyla-
tion of IgAl in IgAN and in HSP with nephritis, but this is not seen in HSP
without nephritis, nor in MN. Altered IgAl 0-glycosylation contributes
directly to renal IgA deposition and the development of glomerular
damage in IgA-associated renal disease.
Diagnostic value of standardized assays for ANCA in systemic vascu-
litis. D.R.W Jayne, G. Gaskin, CD. Pusey, C.M. Lockwood, for the
EC/BCR ANCA Standardisation Study Group (Co-ordinator: FW van der
Woude), Divivion of Renal Medicine, St George's Hospital Medical School,
and Renal Unit, RPMS, London; and Department of Medicine, University of
Cambridge, Cambridge, United Kingdom. ANCA are widely used as
diagnostic markers for the primary systemic vasculitides, Wegener's
granulomatosis (WG), microscopic polyangiitis (MPA) and renal-limited
vasculitis (RLV). The current, standard ANCA test is indirect immuno-
fluorescence (hF). The diagnostic value of ANCA measurement by hF
and by antigenic specific ELISAs for antibodies to proteinase 3 (anti-PR3)
and to myeloperoxidase (anti-MPO), was evaluated in patients with
primary systemic vasculitis. Fourteen centers entered 174 new patients
with WG, MPA or RLV, classified by pre-defined criteria, and the results
compared to 184 disease, and 740 healthy, controls. hF used a standard
method, while the ELISAs were previously standardized between partic-
ipants. Results for the sensitivity of each assay and for the assay combi-
nations, cANCA/anti-PR3 positive or pANCAJanti-MPO positive were
calculated and the specificity of the assays or their combinations compared
to results from the disease controls.
Sensitivity %
Specificity %WG MPA RLV
cANCA (hF) 68 23 36 95
pANCA (hF) 19 58 45 81
anti-PR3 (ELISA) 69 26 50 87
anti-MPO (ELISA) 25 58 64 91
cANCA + anti-PR3 58 10 33 99
pANCA + anti-MPO 17 55 41 99
The value of hF for ANCA detection can be greatly increased by the
addition of antigen specific ELISAs, when the specificity of a positive
combination rises to 99% at the expense of a loss of around 10% in
sensitivity. A number of patients with primary systemic vasculitis remain
ANCA negative.
Detection of renovascular disease (RYD) in elderly patients with
congestive cardiac failure (CCF). P. Macdowell, P.A. Kalra, D.J.
O'Donaghue, S. Waldek, K Brown, and H. Mamtora, Department of Renal
Medicine, Hope Hospita4 University of Manchester, Manchester, England,
United Kingdom. Occult RVD frequently occurs in the elderly, is associ-
ated with generalized atheromatous disease, and is increasingly recog-
nized as a cause of end-stage renal failure. ACEI are widely used in
treatment of congestive cardiac failure (CCF) in an aging population who
are likely to have a high prevalence of RVD. Captopril renography (CR)
is a useful test for the detection of significant renal artery stenosis (RAS 
50% or occlusion) in selected hypertensive patients. Magnetic resonance
angiography (MRA) allows the non-invasive detection of RAS. Seventy-
three patients, aged 70 to 94 years (mean 79.4 years), presenting with CCF
to the Medical unit were recruited. Serum creatinine was 75—289 mol/
liter (mean 185 mol/liter). All underwent CR with MAG-3 prior to the
initiation of ACEI therapy. Captopril 25 mg (oral) was administered 1
hour before the second renogram. Renograms were analyzed semiquan-
titatively. CR was considered positive if: (1) time to peak was delayed >
5 mm; (2) split function changed > 5%; (3) there was > 30% cortical
retention at 20 mm; (4) significant deterioration in shape of the curve
occurred. MRA was performed with a Siemens Magnetron Expert 1.0
tesla using 3-dimensional phase contrast studies. All patients with positive
or equivocal renography and 40% of the 47 patients with negative
renograms underwent MRA; renal artery anatomy was normal in the
latter 19 patients. CR was positive in 26 patients (35.6%). Five patients
had a suspected unilateral occlusion at CR (no isotope uptake) that was
confirmed at MRA, and were able to tolerate ACEI without any decline
in renal function. Five other patients were found to have significant
bilateral RVD (strongly positive CR and RAS  50% at MRA) and were
advised to avoid ACEI. Fourteen patients had unilateral RAS at MRA as
predicted by CR appearance. Two patients had abnormal baseline reno-
grams but had no change or improved post-captopril; these patients had
normal MRA. Further analysis of the epidemiological characteristics
demonstrate a strong link with peripheral vascular disease, smoking and
renal impairment. The prevalence of occult RVD was 32.9% in this elderly
population with CCF. CR had a sensitivity of 100% and a specificity of
92% for detecting RVD in this group, and may predict outcome after
initiation of ACEI.
In vitro and in situ production of IL-8 in ANCA-associated vasculitis. P.
Cockwell, C.J. Brooks, D. Adu, and C.O.S. Savage, Renal Immunobiology,
CCRIS, Medical School, University of Birmingham, Birmingham, England,
United Kingdom. Tissue production of the CXC chemokine hL-8 directs
tissue infiltration and activation of neutrophils. In contrast, intravascular
IL-8 production may disrupt this orderly sequence. We examined (i) the
ability of ANCA to stimulate neutrophil IL-8 production using an ELISA
and (ii) renal IL-8 mRNA expression using in situ hybridization with a
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labeled IL-8 riboprobe in patients with ANCA positive vasculitis. Neutro-
phils were isolated from normal healthy donors, primed using cytochalasin
B and TNFa and stimulated with ANCA rich IgG isolated from the serum
of patients with vasculitis. ANCA stimulated time and dose dependent
IL-8 production, maximal at 200 jrg/ml TgG, with peak levels at 4 to 8
hours. Four out of five ANCA rich IgGs (3/3 pANCA, 1/2 cANCA)
stimulated IL-8 production (max 647 72 pglml/5 >< IO cells). Normal
human lgG was non-stimulating. JL-8 mRNA was expressed by proximal
tubular epithelium and interstitial and glomerular associated inflamma-
toly cell infiltrates in renal biopsies from patients with ANCA positive
small vessel vasculitis. Renal biopsies from non-inflammatory glomerulo-
nephritis were negative for IL-8 mRNA, as were the sense probes. While
tissue IL-8 may direct neutrophil infiltration, we hypothesize that intra-
vascular production of high levels of IL-8 by ANcA-activated neutrophils
may oppose successful migration to extravascular sites. In this situation,
frustrated transmigration of activated neutrophils may contribute to
endothelial injury.
Role of T cell activation in the initiation and progression of chronic
renal allograft dysfunction. A. Chandraker, H. Azuma, K Nadeau, M.
Schaub, W. W Hancock, IV.L. Tilney, C.B. Carpenter, and MH. Sayegh,
Renal Division, Brigham and Women's Hospital, Harvard Medical School,
Boston Massachusetts, USA. (Introduced by Dr. M. Edmunds, Walsgrave
NHS Tmst, Coventry, England, United Kingdom.) Chronic rejection re-
mains the most important cause of long-term renal allograft loss. The
pathogenetic mechanisms of chronic rejection are elusive. We investigated
the role of T cell costimulation in the initiation and propagation of chronic
rejection in an experimental rat transplantation model. We used
CTLA41g, a recombinant fusion protein which blocks the CD28-B7 T cell
costimulatory pathway to inhibit T cell activation. We studied the effects
of CTLA41g when administered early and late post-transplantation. The
following groups were set up (N = 7—30/group):
Group 1 Received CsA (0.5 mg/kg/day, day 0—10)
Group 2 CTLA4Ig (0.5 mg on day 2)
Group 3 CsA plus CTLA41g (as above)
Group 4 CsA (0.5 g/kglday, day 0—10 plus CTLA4Ig (0.5 mg at
8 weeks)
Group 5 Isograft controls
Outcome was measured in terms of survival, proteinuria, morphology and
cytokine expression by RT-PCR. The survival rate was 72% at >100 days
in group 1 compared with 92—100% in the other groups. Animals treated
with CsA alone developed progressive proteinuria and typical changes of
chronic rejection, namely cellular infiltration, glomeruloscierosis and graft
arteriosclerosis. Proteinuria as well as morphologic changes of chronic
rejection were significantly reduced by CTLA41g therapy. Grafts from
CTLA41g treated animals (day 2 and 8 weeks groups) had significantly
decreased transcript levels for activation and inflammatory cytokines and
TGF-13. These data indicate that T cell activation is important in both the
initiation and progression phases of chronic rejection. These observations
should have clinical relevance for organ transplantation.
An association between CMV infection and transplant renal artery
stenosis. 0.1. State, W. Wong, and B.M. Hendy, Renal Medicine, King's
College Hospital, King's College School of Medicine and Dentistry, London,
England, United Kingdom. The stenosis of coronary arteries both after
angioplasty and following cardiac transplantation has been linked to CMV
infection. Similar mechanisms could contribute to the incidence of trans-
plant renal artery stenosis (TRAS) after renal transplantation. We report
a retrospective study of the relationship between TRAS and post-
operative CMV infection in patients transplanted at our center in the
period of 1978 to 1992. Review of all 917 transplanted patients identified
75 patients with TRAS diagnosed on renal arteriography whose records
also allowed the incidence of CMV infection (between transplantation and
diagnosis of TRAS) to be assessed. A case-control group of 75 transplant
patients was identified without TRAS, matched for year of transplant, age
at transplant, sex and number of previous grafts. The incidence of CMV
infection (in the same period as their matched TRAS case) was also
assessed in these patients. Using a combination of clinical and serological
criteria, the patients were divided into those in whom CMV infection was
highly probable (clinical episode, scrologically confirmed), possible and
negative. The incidence of CMV infection in the TRAS and control
patients is tabulated:
TRAS
(N = 75)
Controls
(N = 75)
P
value
CMV highly probable 36 (48%) 12 (16%) <0.05
CMV possible 24 (32%) 30 (40%) > 0.05
CMV negative 15 (20%) 33 (44%) <0.05
We have previously reported an increased incidence of rejection in the
TRAS patients. Analysis of CMV infection in the subgroup of patients
without rejection episodes further increased the relative excess in TRAS
versus controls. The causal basis of these associations remains ill-defined,
but the data support the hypothesis that CMV infection can contribute to
the development of TRAS.
Zinc protoporphyrin assay aids in the identification of functional iron
deficiency in patients on dialysis. B. Wilson and M K Almond, Depart-
ments of Haematology and Medicine, Southend Hospital, Prittlewell Chase,
Westclijf -on-Sea, Essex, England, United Kingdom. The use of recombinant
human erythropoietin (EPO) in patients on chronic dialysis corrects the
anemia of chronic renal failure, providing the patient is not iron deficient.
No single assay adequately identifies patients who are functionally iron
deficient. The most commonly used assay (ferritin) has limitations that
may be resolved by combining other assays to improve specificity and
sensitivity. Zinc protoporphyrin (ZPP) is formed when zinc is substituted
for the ferrous ion during haem synthesis when iron is not available. We
investigated the possibility of combining an assay of erythroeyte ZPP with
ferritin to identify those patients responding poorly to EPO who may have
functional iron deficiency. Fifty-one hemodialysis patients from a single
unit who had been receiving EPO for a minimum of 3 months were
studied. Having excluded accepted causes for EPO resistance, patients
were classified as good or poor responders according to hemoglobin and
EPO dose (U/kg/week). Ferritin and ZPP assays were performed on all
patients. No correlation existed between the ferritin and ZPP levels in
either good or poor responders nor in the pooled data. Of the 13 poor
responders, ii had a high ZPP (> 40 /LM ZPP/mol hem) with a normal
ferritin (> 20 ng/ml) while 2 had both a high ZPP and a low ferritin. There
was no significant difference in ZPP levels between the responders and
non-responders (P = 0.06). There was a significant difference in ferritin
levels between the responders and non-responders (P < 0.01). Combining
the two assays improved the identification of poor responders. The normal
range for ZPP in hemodialysis patients is not established. By adjusting the
normal range of ZPP, sensitivity can be improved and in combination with
a ferritin assay the specificity is increased.
Reticulocyte markers in patients with end-stage renal disease on
hemodialysis. S. Bhandari, J.H. Tumey, and AM. Brownjohn, Renal Unit,
Leeds General Infirmary, Leeds, England, United Kingdom. Measurement
of the hemoglobin distribution with the reticulocyte population enables
one to identify poorly hemoglobinized reticulocytes in advance of any
change in the red cell population as a whole. Mean reticulocyte hemoglo-
bin content (CHr) and mean reticulocyte hemoglobin cell concentration
(CHCMr) are early indices of any change in recent erythropoiesis and may
therefore be of benefit in the early diagnosis of functional iron deficiency
(FID). In a cross-sectional study of 67 hemodialysis patients, mean age 62
years (range 20—63), mean hemoglobin 9.5 0.16 g/dl on s.c. erythropoi-
etin (EPO) and oral iron supplements, reticulocyte markers were com-
pared with standard hematological indices. CHr correlated with mean cell
volume (MCV) (r = 0.527, P < 0.001), mean hemoglobin concentration
(MCH) (r = 0,545, P < 0.001) and red cell ferritin (RCFer) (r 0.344,P = 0.004), while CHCMr correlated with MCI-I (r = 0.315, P = 0.009).
There was no significant correlation of CHCMr or CHr with either serum
ferritin (SF) or transferrin saturation (TS). The sensitivity of a reduced
CHr (normal range 25.8—30.6 pg) to diagnose FID (SF < 100 nglliter,
TS <20%) was 0.77 in both cases, respectively, while to diagnose absolute
iron deficiency (AID) (RCFer <7 ag/ferritin/red cell) was 0.46. The
sensitivity of a reduced CHCMr (normal range 23.5—28.7) to diagnose FID
was 0.62 and 0.47, respectively, while to diagnose AID was 0.25. The
sensitivity of an increase in percentage hypoehromic red cells to diagnose
FID was 0.69 and 0.48, respectively. Five patients with a normal SF and 3
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with a normal TS had reduced CHr levels, while 13 patients with a normal
SF and 17 with a normal TS had reduced CHCMr levels, suggesting FID.
Conclusion: Reticulocyte measures provide evidence of iron deficient
erythropoiesis despite oral iron supplementation as a result of EPO.
Prospective analysis may indicate the potential usefulness of these mea-
sures in real time erythropoiesis during EPO therapy and enable more
effective use of this therapy.
Effective utilization of EPO with intravenous iron therapy. S. Bhandari,
R. Kendall, D. Noifolk, J.H. Tumey, and A.M. Brownjohn, Renal Unit,
Hematology Unit, Leeds General Infinnaty, Leeds, England, United King-
dom. Iron replacement therapy reduces the demand for erythropoietin in
dialysis patients. It has been postulated that iron supply to the bone
marrow is a rate-limiting step in the process of erythropoiesis under
erythropoietin stimulation. We evaluated the use of intravenous iron
(Imferon) therapy for this purpose in hemodialysis patients in a prospec-
tive, non-blinded study of 22 patients (16 male, 6 female, mean age 62.4
years, range 24—80 years). All patients had a serum ferritin (SF) of 60
mg/liter despite oral iron therapy. Patients with high aluminum and PTH
levels, underlying bleeding/hematological disorders or active inflammatory
diseases were excluded. Patients were established on subcutaneous eryth-
ropoietin (EPO) and given Imferon over 7 consecutive dialysis sessions
(total dose 1150 mg) with fortnightly monitoring for 4 months. Median
EPO dose was 4000 U/week (mean 6,050 U/week) pre-treatment and
2,000 U/week (mean 3,700 U) post-Imferon therapy (P = 0.03). No
serious adverse events occurred in the 154 treatment sessions of Imferon.
Two patients experienced nausea and malaise, and one complained of
dizziness, but all completed the course. Mean Hb response remained
constant at 6 and 12 weeks (P = 0.098). SF (P < 0.0001) and red cell
ferritin RCFer (P = 0.004) rose significantly while transferrin saturation
remained static (P = 0.08). This coincided with a sharp increase in
reticulocytes in the first 14 days after commencement of Imferon and a fall
in percentage hypochromic red cells (P < 0.0001). An early decline in
RCFer was apparent. There was no correlation between RCFer and SF.
Imferon therapy is a safe and cost effective method of maintaining/
improving Hb levels in patients with low SF levels despite oral iron
therapy. RCFer is an early marker of functional iron depletion.
Outcome following peritoneal dialysis-related staphyococcal peritoni-
tis. S. Peacock, P. Howe, D. Crook, A. Berendt, and C. Winearls, Nuffield
Department of Medicine and Public Health Laboratory, The John Radcliffe;
Oxford Renal Unit, The Churchill; The Oxford Radcliffe Hospitals NHS
Trust, Oxford, England, United Kingdom. Objectives: To compare the
outcome following continuous ambulatory peritoneal dialysis (CAPD)-
related peritonitis caused by Staphylococcus aureus and coagulase-negative
staphylococci. Methods: Patients were prospectively identified between
July 1990 and November 1995. Endpoints evaluated were: (1) abdominal
complications including abscess formation, need for laparotomy during
infection, and development of adhesions; (2) attributable mortality; (3)
seeding of staphylococci from the peritoneum to distant sites; (4) removal
of the peritoneal dialysis catheter within 1 month of the onset of infection;
(5) cumulative survival of CAPD as the mode of dialysis. Results:
Outcome is shown in the table below.
Staphylococcous Coagulase-negative
aureus staphylococcal
peritonitis peritonitis P
Outcome event (78 episodes) (123 episodes) value
Abdominal complications 5 0 0.008
Attributable mortality 3 0 0.057
Metastatic seeding 0 0 —
PD catheter removal 20 8 <0.0003
Four months after the first recorded episode, 93% of patients remained on
peritoneal dialysis following coagulase-negative staphylococcal peritonitis,
compared with 63% following Staphylococcus aureus peritonitis. Conclu-
sions: This study has demonstrated a clear distinction between peritonitis
caused by Staphylococcus aureus and coagulase-negative staphylococci.
These two diseases should be differentiated both during clinical manage-
ment, and in future studies of natural history and treatment.
West Midlands regional audit of dialysis using renal association quality
standards. S.S. Dhillon and S.A. Smith, Birmingham Heartlands Hospital,
Birmingham, England, United Kingdom. We have developed a system of
automated computer controlled audit of dialysis for end-stage renal
failure which is based on the Renal Association guidelines. Most of the
data is collected automatically using a PROTON clinical database with
direct laboratory links. Current data from this database are analyzed using
software enquiries, and reports can be generated in a few minutes. The
program has been installed in six of the eight renal units in the West
Midlands. During 1995 all eight West Midlands renal units contributed
data on all patients receiving dialysis treatment for end-stage renal failure
(1197 patients, 587 hemodialysis, 610 CAPD). The data collected included
demographic information such as age distributions and death rates,
performance against clinical standards defined by the Renal Association
and information about use of dialysis techniques. The data were analyzed
for presentation using an SPSS statistical software program. Results were
presented in a form which allowed individual units to compare their
performance to each other and to the regional mean. The computerized
system enables virtually instantaneous, local collection of accurate perfor-
mance data which can be repeated at any time interval. There is potential
for expanding the database to include units outside the West Midlands.
In vitro age formation is reduced in PD fluid heat sterilized in a
two-compartment bag. A. Dawnay, A.P. Wieslander, and D.i Millar,
Department of Clinical Biochemistry, St. Bartholomew's Hospital, London,
England, United Kingdom; Gambro Group, Lund, Sweden. Peritoneal
membrane function may be impaired by advanced glycation endproduct(AGE) formation which is promoted in PD fluid by unknown factors in
addition to glucose. Since AGE formation is more rapid in PD fluid after
heat sterilization, the factors may be highly reactive glucose degradation
products. Their formation is substantially reduced if the glucose and
electrolyte components are heat sterilized separately. The aim of this study
was to assess whether AGE formation in such a fluid is reduced. PD fluid
(1.5% glucose, Gambro Lundia AB) was heat sterilized in either a single
bag (standard) or with the glucose and electrolytes separated in two
compartments and then combined before use (PD-Bio) such that the final
composition of each was identical. HSA (1 g/liter) was incubated in these
fluids at 37°C, pH 7.4, for up to 30 days. HSA glycation was assessed by
boronate affinity chromatography and RIA, and AGE formation by
fluorescence (Ex330, EM430). The table shows fluorescence (F) in U/g
HSA/l at each time point and fluorescence generation rate (FGR) per day
for each interval.
Days
0 1 2
Standard F
PD-Bio F
Standard FGR
PD-BIO FGR
48
57
238
66
286
123
91
32
377
155
Days
5 10
Standard F
PD-Bio F
Standard FGR
PD-BIO FGR
64
12
568
191
9.4
7.6
615
229
Days
20 30
Standard F
PD-Bio F
Standard FGR
PD-BIO FGR
AGE formation was increased (P < 0.05) in standard PD fluid compared
with PD-Bio. This increase was due to an enhanced FGR in the first 5 days
786
285
17.1
5.6
892
421
111.6
13.6
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of incubation, rates thereafter being similar between the two fluids. There
was no difference (P > 0.05) in glycation rate. Our data are consistent with
glucose degradation products being even more significant than glucose in
promoting AGE formation in PD fluid.
Reactive oxygen species generation, membrane biocompatability and
the role of vitamin E. P. Carmichael, L. Gallivan, B. Walker, and A.M.
Davison, Department of Renal Medicine, Clinical Oxidant Group, St. James's
University Hospital, Beckett Street, Leeds, England, United Kingdom. The
process of contact to artificial surfaces during hemodialysis activates
leukocytes leading to formation of reactive oxygen species (ROS) which
oxidatively modify low-density lipoprotein (LDL) cholesterol; a funda-
mental process in the development of atherosclerosis. The aim of this
study was to assess: (i) ROS production during hemodialysis using three
filters of differing hiocompatability; (ii) the effect of pre-dialysis treatment
with vitamin E on ROS production during hemodialysis. A dose of 890 IU
of vitamin E was administered 18 hours prior to each dialysis; the timing
was chosen to coincide with maximal plasma levels. Blood sampling was
performed at 0.5, 15, 30, 60 and 180 minutes into dialysis.
Patient Cuprophane Modified celluose
Vitamin E
A
B
—
58.7%
60.3%
+
51.7%
45%
—
60.3%
67.4%
+
55.9%
58%
Patient Polysulphone
Vitamin E
A
B
—
63.9%
59.8%
+
54.8%
69%
The table shows percent reduction in plasma total anti-oxidant capacity
(TAC) at 180 minutes compared to pre-dialysis value before (—) and after
(+) vitamin E pre-treatment for two patients.
The results demonstrated a significant reduction in plasma TAC during
dialysis and a transient increase in lipid peroxidation (LPO) values for all
three filters. Pre-treatment with vitamin E resulted in a decrease in plasma
TAC for all three membranes in one of the patients, and for two of the
membranes in the other patient. Pre-treatment with vitamin E had no
effect on LPO production. These studies are being extended to a further
4 patients. We conclude that vitamin E may have a protective role against
long-term cardiovascular morbidity in the hemodialysis population.
Increased cell protein oxidation in hemodialysis. J.G. Anderton, T.H.
Thomas, and R. Wilkinson, Department of Medicine (Nephrology), Univer-
sity of Newcastle Upon Tyne, Newcastle Upon Tyne, England, United
Kingdom. Susceptibility to cell damage by reactive oxygen species (ROS)
is increased in renal failure. Protein thiol (—SH) residues are of wide-
spread functional importance: they are vulnerable to oxidation and may
therefore be targets for damage by ROS. We have measured thiol
complement in mononuclear leukocytes (MNL) from 14 normal controls
(NC), 16 hemodialysis (HD), 13 peritoneal dialysis (CAPD), and 16
chronic renal failure (CRF) patients. Comparison was made with protein
carbonyl levels as a corroborative marker of protein oxidation. At
baseline, fast-reacting thiol was depleted in HD compared to NC (HD
2.46 0.25 vs. NC 3.56 0.24,? = 0.003. Values in nmol SH/106 cells
SEM). After exposure to oxidant stress both total thiol and fast reacting
thiol were lower in lID than NC (total thiol, fast-reacting thiol, rate of
thiol recovery and protein carbonyl levels did not differ significantly
between normal controls, CRF and CAPD patients. Cellular protein
oxidation is increased in HD patients, accompanied by loss of thiol
residues and a reduced capacity to recover thiols after oxidant stress. This
may be a sequela of the oxidant Stress imposed by hemodialysis, and may
have important functional effects on thiol-depcndent cellular proteins.
Increased antioxidant activity of uremic plasma. J.G. Anderton, T.H.
Thomas, and R. Wilkinson, Department of Medicine Nephrolo,) University
of Newcastle Upon Tyne, Newcastle Upon iyne, England, United Kingdom.
Susceptibility to oxidant stress is increased in renal failure, and haemodi-
alysis itself may exacerbate uxidant damage. Conventional antioxidants (eg
vitamin C,E) are depleted, but other substances may contribute to the
antioxidant capacity of plasma. We have used a chemiluminesccnt assay to
measure the plasma antioxidant activity (AOA) of controls (NC), CRF
(median creatinine 490 mol/liter), CAPD and haemodialysis (HD)
patients, before and after a dialysis session. Comparison was made with
Trolox, a vitamin E analogue.
Subjects Number AOA (ILM Trolox)
NC 16 418.8 19.0
CRF 10 652.4 56.Oa
HD (pre) 15 556.3 31.2k'
HD (post) 15 384.8 12.8"
CAPD 14 468.4 27.2
Values are mean SEM; Student's t-test; "P = 0.002 vs. NC; b P = 0.001
vs. NC; "P < 0.0001 vs. HD (pre).
AOA was increased relative to NC in both CRF and HD patients, but was
normal in CAPD. HD acutely reduced AOA to control levels [P = 0.15
HD (post) vs. NC. Urate is a scavenging antioxidant which may be
elevated in uremia and acutely reduced by HD. Although urate was an
effective antioxidant in this assay (0.2 mM urate = 640 rmol Trolox/liter),
the probability of a correlation between changes in AOA and urate (r
0.38) was only P = 0.1. Plasma AOA is increased in uremia, and
hyperuricemia is at most a minor factor in this increase. Acute hemodi-
alysis adversely affects plasma antioxidant status.
Nutritional status and correction of acidosis by high bicarbonate
dialysis. A.J. Williams, ID. Dittmer, J. Clarke, A. McArley, and R.A. Banks,
Renal Unit, Gloucestershire Royal Hospital, Gloucestershire, England,
United Kingdom. Long-term metabolic acidosis is harmful to protein and
bone metabolism in CRF. Standard bicarbonate dialysis cannot always
correct acidosis adequately. This study was to investigate the longer-term
efficacy of high bicarbonate dialysis on controlling acidosis, and its effect
upon nutritional status. Forty-six stable hemodialysis patients, in two
groups, were dialyzed in a single blind double crossover trial for two six
month periods, using low (L.Bic, 30 mmol/liter) and high (H.Bic, 40
mmol/liter) dialysate bicarbonate concentrations. All patients had previ-
ously been dialyzed for at least 6 months using 35 mmol/liter bicarbonate
dialysate. Predialysis arterial plasma pH (L.Bic, 7.38 0.05, H.Bic, 7.43
0.04) P < 0.001, bicarbonate (L.Bic, 22.4 2.9, H.Bic, 27.4 3.0
mmol/liter) P < 0.001, and pCO2 (L.Bic, 5.14 0.57, H.Bic, 5.57 0.55,
kPa) P < 0.01, all different significantly. Predialysis arterial P°2 did not
differ (L.Bic, 11.67 1.69; H.Bic, 11.12 1.39 kPa) neither did P°z values
during 4 hours hemodialysis. No significant sustained differences in
predialysis plasma calcium, phosphate or albumin were found. After 3
months of high bicarbonate dialysis, a predialysis venous bicarbonate of
<20 mmol/liter was seen in one patient only. KT/V (L.Bic 1.27 0.19,
H.Bic 1.27 0.25), UGR (L.Bic 1.99 0.77, H.Bic 1.92 0.77 mmol/min)
and NPCR (L.Bic 1.04 0.26, H.Bic 0.99 0.28 g/kglday) did not differ
during treatment periods. Triceps skinfold thickness changed significantly
(L.Bic 14.8 6.9 to 11.8 5.5, H.Bic 14.9 6.3 to 15.8 6.4 mm; P =
0.018) and the changes reversed following dialysate change (H.Bic 11.8
5.5 to 13.3 7.2; L.Bic 15.8 6.4 to 13.8 6.7 mm P 0.034). Mid-arm
circumference did not change. This study shows that alteration of acid
base status can affect nutritional parameters in the longer-term, and that
individual prescription of dialysate bicarbonate would be an effective way
of controlling acidosis.
Renal transplant experience in Asian children. N.E. Moghal, D.V.
Milford, S.A. Hulton, and CM. Taylor, Department of Nephrology, The
Birmingham Children's Hospital, Ladywood, Birmingham, England, United
Kingdom. We undertook a retrospective study of renal transplantation
between 1980 and 1995 in an Asian population (Indian, Pakistani,
Bangladeshi). Asian children account for 7.4% of the total child popula-
tion (0—15 years) in the West Midland Health Region served by the
regional renal service at the Birmingham Children's Hospital. End-stage
renal disease (ESRD) developed in 165 children (138 non-Asian, 27
Asian) during this time. The prevalence of ESRD for the non-Asian
cohort was 15/10 non-Asian child population and for Asians, 40/10 Asian
child population. Genetic diseases accounted for 26 (19%) in non-Asians
and 12 (44%) in Asians progressing to ESRD (P < 0.001). Of the 147
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grafts, 22 were Asian recipients (15%). The percentage grafted in the
Asian cohort increased over the 15 year period: 1980—84, non-Asian 54%
vs. Asian 0%; 1985—90, non-Asians 64% vs. Asians 50%; 1991—95,
non-Asian 82% vs. Asian 86%. The distribution of blood groups in the two
populations reflected the pattern in the respective general population as a
whole: Asians 0 = 32%, A = 16%, B = 47%, AB = 5%; non-Asians 0 =
55%, A = 35%, B = 7%, AB 3%. Time to transplantation was 1—44
months (mean 7 months). Despite the different distributions of blood
groups between the two populations there was no significant difference in
the time to transplantation (non-Asians mean 6 months, 95% Ci 0.6—0.9;
Asians mean 7 months, 95% CI 0.3—1.0). Asian patients had significantly
(P < 0.001) more mismatches (3 or compared to non-Asians. There
was a higher prevalence of ESRD in the Asian child population, with
genetic disease accounting for a significantly higher percentage compared
to the non-Asian population. Differences in blood groups did not influence
time to transplantation between the two populations, although Asians had
significantly more mismatches compared to the non-Asians.
Indo-Asian dialysis and transplant rates. R.M Higgins, N. West, M.E.
Edmunds, D.C. Dukes, H. Kashi, and F. T. Lam. Dialysis and Transplant
Units, Walsgrave Hospital, Coventiy, England, United Kingdom. HLA
matching between donor and recipient in cadaver renal transplantation
has been increasingly utilized. Since 1988, 98.0% of the kidneys trans-
planted in our center have had only 0 or I DR mismatch between donor
and recipient. We have analyzed our activity from 1988—1995 inclusive.
We serve an adult population of 597,046 White Europeans and 26,869
Indo-Asians (1991 census). Dialysis and transplant rates have been
calculated per million population per year (pmp/yr).
Europeans
N, pmplyr
Indo-Asians
N, pmp/yr P
Started dialysis 395 (82.6) 71(330.3) <0.001
On transplant waiting list 254 (53.1) 51(237.2) <0.001
Transplanted 176 (36.8) 21(97.6) <0.001
Donor kidneys 192 (40.1) 2 (9.3) <0.025
Indo-Asian patients registered for transplantation were less likely to
receive a kidney than White European patients (31% vs. 58%, P < 0.025);
those transplanted waited longer [mean times on list 403.4 (suM 134.4) vs.
331.7 (suM 33.3) days respectively, P < 0.05)1 and were more likely to
remain on the waiting list for over 750 days without being transplanted
(33.3% vs. 19.4%, respectively, P < 0.025). In summary, allocation of
kidneys by HLA matching and a kidney shortage both contributed to a
relative disadvantage for individual Indo-Asian patients awaiting trans-
plantation.
Early induction of TGF.pl in transplantation. M. Picton, S. Williams,
IS. Roberts, CD. Short, R. W. Johnson, P.E. Brenchley, Renal Research
Group, Manchester Royal Infirmaty, OxJbrd Road, Manchester, England,
United Kingdom. The major cause of chronic vascular rejection (CVR) in
renal transplantation is intimal thickening initiated by an accelerated
inflammatory, fihro-prolifcrative response to injury and culminating in
sclerosis of small arteries. Acute rejection, infection and hypertension may
he implicated in this process in some patients and is probably modulated
by raised circulating TGF-131, secondary to deranged regulation of this
pro-fibrotic cytokine. Therefore, we studied 82 sequential renal allograft
recipients during the first 12 months following transplantation. Plasma
samples were collected daily during hospitalization and at every subse-
quent out-patient clinic visit. Plasma TGF-pl levels were determined by
immunoassay. Biopsy material from 14 patients was processed for immu-
nostaining. Thirty-one of the patients (37.8%) had detectable TGF-f31
(plasma >100 pg/mI) and were positive over a range of 1—134 days with a
mean duration of 36 days. There was a higher incidence of CMV disease
(P> 0.05) and other infections (P> 0.01) in the TGF-1 positive patients.
There was no significant difference in the number of acute rejection
episodes or episodes of ATN between the TGF-i positive patients and
the negative group. The rise in TGF-1 was associated with acute
rejection (1), chronic rejection (1), CMV infection (4), other infection (7),
surgery (7), ATN (2), CSA toxicity (1) or unknown (8). Immunostaining
for TGF-f31 and TGFRI1 protein was no different from normal. Thus,
raised levels of TGF-1 have been documented in association with a
number of events following renal allograft transplantation. Long-term
sequential follow-up will be necessary to determine whether this has an
adverse outcome with regards to allograft function.
Can cyclosporin failure be converted to tacrolimus success in renal
transplantation? S.S. Dhillon, M.E. Edmunds, D.C. Dukes, H. Kashi, F. T
Lam, and R.M. Higgins, Dialysis and Transplant Units, Walsgrave Hospital,
Coventry, and Birmingham Heartlands Hospital, Birmingham, England,
United Kingdom. In the pre-tacrolimus era, failure of cyclosporine to
prevent acute rejection required augmentation of immunosuppression
with high dose steroids or protein immunosuppression, which was often
associated with either graft failure or the adverse side-effects of treatment.
We have reviewed our use of tacrolimus for biopsy proven rejection in 13
patients on primary cyclosporine immunosuppression. The mean time to
conversion after transplantation was 461 days (range 46—1718), and the
mean creatinine level at conversion was 367 jmol/liter (range 190—823).
The mean cyclosporine trough level through which rejection occurred was
188 mmol/liter. Graft survival after conversion is currently 70% with a
mean follow-up in functioning grafts of 211 days (range 38—370). The 3
failures were patients already on dialysis, due to graft rejection, at the time
of conversion. Six cases had received courses of OKT3 before conversion.
Conversion was associated with only a levelling in plasma creatinine levels,
presumably due to nephrotoxicity. Twenty days after conversion the mean
creatinine level in 11 functioning grafts had risen from 310 jLmol/liter
(range 190—554) to 320 mol/liter (range 162—503), a mean change of
+3.2%. The most recent creatinine levels were 298 jLmol/liter (range
151—444) in 10 functioning grafts, a mean change of +4% compared to
pre-conversion levels in these grafts. There was 1 case of intestinal
lymphoma which has gone into spontaneous remission and 1 case of CMV
pneumonitis associated with graft failure; both patients had received
OKT3. In summary, we have identified renal transplant patients in whom
cyclosporine has failed. Conversion to tacrolimus has been associated with
stabilization of renal function in otherwise failing grafts, but also with
possible nephrotoxicity.
T-cell adhesion processes in ANCA positive glomerulonephritis. S.J.
Chakravorty, A.J. Hosvie, P. Cockwell, D. Adu, and C.O.S. Savage, Renal
Immunobiology, CCRIS and Department of Pathology, Medical School,
University of Birmingham, Birmingham, England, United Kingdom. The
focal segmental necrotizing glomerulonephritis of ANCA positive small
vessel vasculitis (SVV) is associated with glomerular and tubulointerstitial
T-cell infiltrates. Interactions of the T-cell expressed u4/31 integrin
(VLA-4) and its dual tissue ligands, CS-i containing fibronectin and
vascular cell adhesion molecule-i (VCAM-1), are believed to play key
roles in T-cell trafficking in immune and inflammatory disorders. We have
developed a modified Stamper-Woodruff assay to produce a functional
system to assess leukocyte adhesion requirements in inflammatory renal
diseases. We studied SVV (6) and normal tissue (4). T lymphocytes
(Jurkat cell line) in suspension were added to renal biopsy sections in the
absence and presence of blocking antibodies to VLA-4 (Max 68) and CS-I
(90.45). Cells and tissue were co-incubated and adherent cells were
visualized by an anti-CD3-HRP conjugate. There was minimal binding of
unstimulated cells to normal and vasculitic tissue or of preactivated cells
to normal tissue. Preactivated cells bound to vasculitic sections within
glomeruli, to parictal epithelium, interstitium and to the luminal aspect of
proximal tubular epithelium. Binding was inhibited by anti-VLA-4 (32.4
8.2%) and anti-CS-i (58.4 6.3%), with anti-CS-i preferentially inhibit-
ing interstitial binding. The two antibodies in combination produced a
dramatic reduction (75.5 8.9%), but not complete inhibition of T-cell
binding. These data suggest that in SVV: (i) VLA-4 mediated adhesion
processes play a pivotal role in T-cell infiltration; (ii) T-eell activation is a
requirement for adhesion in this assay system; and (iii) VLA-4 indepen-
dent adhesion processes also have a role in T-cell trafficking.
ANCA stimulates IL-ip and IL-6 production from TNF.a primed
neutrophils. CR. Myers, D.J. O'Donoghue, and P.E.C. Brenchley, Depart-
ment of Renal Medicine, Hope Hospital, Salford; Renal Research Group, St.
Ma,ys Hospital, Manchester, England, United Kingdom. Anti-neutrophil
cytoplasmic antibodies (ANCA) have the potential to interact with primed
neutrophils (PMN) through Fab binding to antigen displayed on the
plasma membrane and through Fe binding to the FcyRlI. ANCA are
known to induce production of reactive oxygen species and degranulation
of primed PMN. ANCA may modulate other neutrophil functions. This
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study investigated the potential modulation of neutrophil cytokine pro-
duction in response to ANCA stimulation. PMN were isolated from six
healthy volunteers, to a purity of >99% and cultured At 37°C and 5% CO2
at 0.5 X 106/ml. Cells were primed with 20 ng/ml TNF-a for 20 minutes
then stimulated with 100 zg/ml IgG isolated from serum from biopsy
proven vasculitis patients (10 pANCA, 6 cANCA) and from normal
individuals (10) for 6 hours. Supernatants were assayed by ELISA using
chemiluminescent detection for IL-13, IL-6 and IL-8 production. ANCA
induced significantly higher production of IL-1j3 and IL-b than did normal
IgG but no significant difference in production of IL-8.
IL-lp pg/ml 1L-6 pg/mI IL-8 pg/mI
ANCA IgG (16) 147 95 67 23 2283 375.5
Normal IgG (12) 87 36.8 41.5 14.8 2074
2-tailed Student t-test: P = <0.05, P = < 0.005, P = <0.191.
Values = mean and SD.
pANCA lgGs stimulated higher levels of IL-1/3 and IL-6 than did
cANCA5(230.7pg/ml ilSvs. 125.SpgIml 105,P< 0.001 and8l.43
30 pg/mI vs. 64.2 pg/mI, P> 0.005, respectively). Although ANCA activity
was present in all IgG subclasses, IgG2 and IgG4 predominated and a
significant relationship between the presence of IgG4 and IL-6 production(P = 0.007, 2 tailed Student t-test) was apparent. F(ab)'2 ANCA preps
failed to stimulate detectable IL-1f3 and IL-6 production, indicating
dependence on FcR interaction. We propose that ANCA induced cyto-
kine production may prolong neutrophil survival and enhance neutrophil
mediated tissue damage, sustaining the bias toward a pro-inflammatory
environment.
Expression of intracellular and secreted recombinant proteinase 3
recognized by ANCA. ME. GnJJlth, AN. Turner, J. McVey, and C.D. Pusey,
Renal Unit, Department of Medicine, and MRC CSC, Royal Postgraduate
Medical School, London, England; Department of Medicine and Therapeu-
tics, University of Aberdeen, Aberdeen, Scotland, United Kingdom. PR3 is
the major autoantigen of cANCA in systemic vasculitis. However, it is
difficult to purify from human neutrophils, and we have therefore at-
tempted to produce recombinant protein which retains its antigenicity.
RNA was extracted from human bone marrow and reverse transcribed.
PR3 specific eDNA was then amplified by PCR, cloned into pUC19, and
sequenced. Different expression systems were then investigated. The
baculovirus/inseet system was initially used for expression. Full length
eDNA for PR3, including that encoding the prepropeptide, was cloned
into PVL 1392. This was contransfected with BACPAC 6 into SF9 insect
cells, and recombinant viral clones identified by PCR with PR3 specific
primers. Cytospins of cells infected with virus for 72 hours were made and
incubated with test antibodies. There was positive immunofluorescence in
the plasma membrane of cells infected with recombinant virus following
incubation with 2/3 anti-PR3 monoclonal antibodies, and with 4/5 cANCA
positive sera, but not with control sera. Cells infected with wild type
baculovirus were negative on immunofluorescence with all test antibodies.
Thus, PR3 was expressed in an antigenic form, but was not secreted.
Secondly, using an E. coli expression system, eDNA for PR3 was cloned
into a vector encoding the 5Th enterotoxin secretory leader. This results
in expression of a secreted product which is cleaved from the secretory
peptide as it is exported from the cell, and which tends to remain soluble.
Following induction with IPTG, cells transformed with this recombinant
vector produced a secreted protein of 30 kDa. This was identified on
Western blotting by cANCA positive sera from 4/4 patients, but not by
control sera. It was also recognized by 1/3 anti-PR3 monoclonal antibod-
ies. This product contains the prepropeptide of PR3, which may have
affected binding of the monoclonals. Nonetheless, PR3 was expressed and
secreted in an antigenic form. In summary, we have produced recombi-
nant PR3 recognized by ANCA in both insect cells and E. coli. It should
be possible to isolate the secreted form in large quantities. This will
facilitate basic research in vasculitis as well as being potentially useful for
clinical assays.
Peripheral mononuclear cells express VEGF and the VEGE receptor
fit-i. N.J.A. Webb, Cf. Watson, M.J. Bottomley, and P.E.C. Brenchley, Renal
Research Group, Si. Mary's Hospital, Manchester, England, United King-
dom. Vascular endothelial growth factor (VEGF) is a potent modulator of
capillary permeability, an endothelial cell mitogen, and is a chemoattrac-
tant for monocytes. Peripheral mononuclear cells (PMC5), central to the
pathogenesis of many glomerulopathies, have been shown to express
VEGF and fit-i mRNA, though protein production has not previously
been reported. PMCs were isolated from healthy adult volunteers (N =
11) by Ficoll centrifugation, resuspended in Iscoves/10% FCS at 2 x
106/ml and stimulated with PHA (0—25 jrg/ml) and LPS (0—10 ng/ml) at
37°C for varying time intervals between 0 and 96 hours. Free VEGF levels
in the culture supernatants were measured using a novel sensitive chemi-
luminescent assay which utilizes soluble r-VEGF receptor fit-i for capture
and a rabbit polyclonal anti-VEGF antibody for detection, and thus
measures free VPF but not VEGF-fit-1 complexes. VEGF-fit-1 complexes
were measured by a second assay utilizing antibodies to fit-i and VEGF.
Total RNA isolated from cell pellets was submitted for semiquanti-
tative RT-PCR studies for all three common VEGF splice variants
(VEGF12I, 165 and 189) and also both membrane bound and soluble
variants of the VEGF receptor fit-I. PMCs stimulated with LPS showed
significantly increased VEGF production compared with unstimulated
controls (0) at all doses though maximal at 1 ng/ml (561 pg/mI vs. 213
pg/mI at 24 hours, P = 0.018), with peak production at 72 hours [965 pg/mI
(1 nglml) vs. 415 pg/mI (0), P = 0.00021. PHA stimulated cells also
showed increased protein production compared with 0, with the maxi-
mum response occurring with 0.1 ,ag/ml at 72 hours (633 pg/mI vs. 113
pg/mI, P = 0.01). LPS stimulated shedding or secretion of fit-i with peak
VPF-fit-i complex levels at 72 hours. Semiquantitative RT-PCR studies
identified up-regulation of mRNA in LPS stimulated cells for all three
VEGF splice variants and also for both membrane bound and soluble fit-i
variants at 8 hours compared with control samples. Thus, PMCs may play
a pivotal role in the production of VEGF and the control of its bioactivity
via fit-i secretion.
Heterogeneity of endothelin receptors and endothelin production in a
renal cell line. A.F. James, NA. Parkinson, and B.M. Hendty, Renal
Research Group, Department of Medicine, King's College School of Medicine
and Dentistry, London, England, United Kingdom. Endothelins (ETs) have
been implicated in the progression of renal failure and may be involved in
tubulo-interstitial fibrosis. However, the role of direct actions of ETs on
tubule cells remains unclear. We have recently defined the actions of ETs
on Ca homeostasis in MDCK cells, a cell line from canine renal tubule.
This report concerns ET production and ET receptor expression in
MDCK cells. Cells were grown to confluence in 24-well culture plates.
Immunoreactive (i.r.) ET released into the culture medium was assayed by
ELISA. Specific binding to cultured cells was measured after incubation
with [1251]ET-1 (74 TBq/mol) at 37°C for 2 hours. Two subtypes of MDCK
cells were identified according to their production of ETs and receptor-
binding properties. MDCK-a cells produced low, but significant, levels of
i.r. ET; 12.2 5.4 fmol/well/24 hours. Binding of 30 M [1251]ET-1 to these
cells was concentration-dependently displaced by ET-l > BQ-123 > ET-3,
suggesting binding to ETA type receptors. In contrast, MDCK-h cells
produced 13-fold more i.r. E.T (161.9 16.7 fmol/well/24 hours) than
MDCK-a cells. Binding of 30 prvi ['251jET-1 could not be detected in
untreated MDCK-b cells. However, treatment of MDCK-b cells with the
non-selective endothelin-converting enzyme inhibitor, phosphoramidon (4
mM, 48 hours), increased the binding of 500 pM ['2511ET-1 to these cells
from 354 8 cpm/well to 4480 459 cpm/well, suggesting that ET
produced by these cells may hind to and mask the ET receptors present.
ELISA confirmed that phosphoramidon treatment had reduced the i.r. ET
of the culture medium from these cells by a factor of 5. Binding of 500 pM
['2511ET-i to these MDCK-b cells was inhibited by both ETA-selective
BQ-123 (1 jrrvi; 36.5%) and ET-selective BQ-788 (10 nM; 74%), suggest-
ing the existence of both ETA and ET0 receptors on MDCK-b cells.
Production of jr. ET by MDCK-b cells was not affected by 24-hour
incubation in the presence of either BQ-123 (I jLM) or BQ-788 (10 nM).
These results show that phenotypic variation in this cell line includes the
expression of both ETA and ET0 receptors and suggests that responses to
exogenous ETs may be inhibited by receptor-hound endogenous ET.
inhibition of diabetic hyperfiltration via peptide antagonism of the type
1 IGF receptor. H.M. Hickling, fL. Haylor, CA. Hardisly, and AM. El
Nahas, Sheffield Kidney Institute and Diabetic Centre, Northern General
Hospital Tn1st, Sheffield, England, United Kingdom. Insulin-like growth
factor I (IGF-i), IGF-1 binding proteins and IGF-I receptor proteins are
all modified early on in the diabetic kidney, and hence TGF-1 has been
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proposed as an important mediator of diabetic kidney growth. IGF-I
infusion results in an elevated GFR, which would also suggest a role for
this growth factor in diabetic hyperfiltration. Seven days after the induc-
tion of diabetes by i.v. streptozotocin (45 mg/kg), diabetic hyperfiltration
was measured using an isolated perfused rat kidney (IPRK) preparation.
GFR was assessed as the clearance of ['4C1 inulin. The role of IGF-I was
established using JB1 (1 rg/ml), a 12 amino acid peptide antagonist of the
type 1 IGF receptor. The use of the IPRK model avoided the systemic
metabolism of JB1 and also distinguished between the kidney and the
systemic circulation as a source of IGF-I. Diabetic rats had a two-fold
higher GFR throughout the perfusion period (P < 001, N = 6) when
compared to non-diabetic controls. In kidneys perfused from diabetic rats,
the addition of JB1 (1 .rg/ml) to the perfusate produced a significant fall
in GFR of 44% (1.08 0.16 to 0.64 0.17 mI/mm, P < 0.01, N 6)
similar to the level detected in kidneys obtained from non-diabetic rats
following JB1 administration. In the absence of JB1, kidneys perfused
from diabetic rats showed only a small decrease in GFR (12%) throughout
perfusion. The effectiveness of JBI as an antagonist for the type 1 IGF
receptor was verified by inhibition of the renal vasodilator response to
exogenous recombinant human IGF-I. In conclusion, the results suggest a
role for renal IGF-1 in mediating diabetic hyperfiltration, independent of
changes in kidney growth.
Low density lipoprotein enhances monocyte bonding to human mesan-
gial cells. R.S. Channa and D.C. Wheeler, Department of Nephrology,
University Hospital NHS Trust, Queen Elizabeth Hospital, Birmingham,
England, United Kingdom. Glomerular monocyte infiltration is a recog-
nized early histopathological feature of lipid-mediated renal injury in
cholesterol-fed rats and other animal models of glomerulosclerosis. Inter-
actions between infiltrating leukocytes and mesangial cells might contrib-
ute to glomerular injury. To determine whether lipoproteins might
enhance this process, binding of U937 monocytes to low density lipopro-
tein (LDL)-prestimulated human mesangial cells was studied in vitro by
colorimetry of nuclear staining using crystal violet. LDL enhanced adhe-
sion in a time- and concentration-dependent manner. Maximum binding
was observed after 24 hours prestimulation with 100 .rg/ml lipoprotein
when mean SD monocyte adhesion was increased by 268 5.5%
compared to unprimed cells (100%) (P < 0.005). Similar results were
obtained using minimally modified LDL (MM-LDL) that had been mildly
oxidized by prolonged storage. Under the same experimental conditions,
adhesion to cells pre-stimulated with 100 U/mI tumor necrosis factor a
(TNFa) was 387 4.2% of control. In an attempt to elucidate the
mechanisms of enhanced monocyte binding, mesangial cell expression of
intercellular adhesion molecule-I (ICAM-1) and vascular cell adhesion
molecule-i (VCAM-I) was studied using an ELISA. While LDL had no
effect, a small increase in IcAM-I but not VCAM-1 was detected after
pre-stimulation with MM-LDL. At a concentration of 100 pg/mI MM-
LDL and after 8 hours pre-stimulation, ICAM-1 was increased to 130.0
8.8% of control (P <0.005), a modest effect when compared to that of 100
U/mI TNFa (349 9.9%). When cells were primed with TNFa prior to
lipoprotein stimulation, both LDL and MM-LDL led to an increase in
IcAM-l hut not VCAM-1 expression. These results suggest that lipopro-
teins might promote mesangial cell-leukocyte interactions and that en-
hancing expression of cell surface adhesion molecules may at least in part
facilitate this process.
Analysis of urinary proteins by 2D-gel electrophoresis. P.S. Williams,
and M Longlands, Department of Medicine, North Manchester General
Hospital, Crumpsall, Manchester, England, United Kingdom. The magni-
tude of proteinuria is the strongest independent risk factor for progression
of renal failure. However, little is known of the type of proteins excreted.
Urine was obtained from 45 (28M, 17F) adult patients for fiat bed 2D
electrophoresis, desalted using Millipore Ultrafree filter units and redis-
solved in urea solution. The first dimension was run between pH 3 and
10.5 using Pharmacia Immohiline Dry strips, the second on Pharmacia
Excel Gel SDS gradient 8—18. Visualisation was by silver stain. Sixty-three
gels were run. Renal pathology was glomerulonephritis (19), diabetic
nephropathy (6), vasculitis (3), chronic pyelonephritis (3), polycystic
kidneys (3), primary tubular disorders (7), others (4). Proteinuria was 1.8
(0.2—6.4) g/liter and plasma creatinine 184 (57—570) jsmol/liter (mean
range). Twenty-eight (5—65) individual proteins were identified, with MW
10—200 kDa. Higher MW (>50 kDa) proteins exhibited a reproducible,
consistent pattern. Little or no immunoglobulin was seen in 4 patients with
minor glomerular lesions hut also in membranous GN (I), IgA GN (2),
hypertensive nephrosclerosis (2), and diabetic nephropathy (1). Neither
the level of proteinuria nor plasma creatinine influenced the pattern.
Proteins >170 kDa were seen in vasculitis (3) but also in idiopathic GN
(3). Urine from patients with primary tubular disorders contained low
MW proteins and albumin only, but patients with chronic pyelonephritis
and renal impairment had patterns similar to those seen in idiopathic
glomerulonephritis. The pattern of proteinuria therefore was independent
of the underlying renal pathology and was unrelated to renal function or
the magnitude of proteinuria. If proteinuria is pathogenic it appears
independent of the type of protein excreted.
ACE gene polymorphisms and disease severity in HSP nephritis. J.A.
Dudley, A. Gardiner, El. Tizard, and ME. McGraw, Department of
Paediatric Nephrology, Southmead Hospital, Bristol, England, United King-
dom. It has recently been reported that the rate of progression in renal
disease in patients with IgA nephropathy is significantly worse in patients
homozygous for the deletion (D) polymorphism in intron 16 of the gene
for angiotensin-converting enzyme. We are currently investigating the
influence of insertion (I) and deletion (D) polymorphisms in patients with
Henoch-Schönlein nephritis seen in our unit over the last 13 years.
Twenty-two patients have been investigated to date. DNA was obtained
from buccal scrapings using a dry sterile cytotak brush. ACE genotype was
established by PCR reaction. The distribution of genotype was as follows:
11:4, ID:12 and DD:6 patients. Mean age at presentation in these groups
was 3 years 4 months, 7 years 1 month and 7 years 5 months, respectively.
Length of follow-up is 6 months—13 years. Severe onset with nephrotic
edema, hypertension and crescent formation on renal biopsy was seen in
7/12 patients with ID genotype, 1/6 patients with DD genotype and 0/6
patients with II genotype. In the ID group, 2 patients have received a renal
transplant; 3 have persistent proteinuria 3, 5 and 9 years after presenta-
tion; one of whom is hypertensive. The remaining patients have made a
complete recovery or have microscopic hematuria alone. All the patients
in the II and DD group have either no urinary abnormalities or have
microscopic hematuria at follow-up of 6 months to 13 years. These
preliminary results suggest that the ID genotype is more likely to be
associated with more severe renal disease than the II and DD genotype.
Interleukin-12 modifies mercuric chloride induced T-helper lymphocyte
type 2 autoimmunity. Mi. Gorrie, C.J. Whittle, KM. Gillespie, E.M. Bolton,
and P. W. Mathieson, Western Infirmary Renal Unit, Glasgow, and Academic
Renal Unit, Southmead Hospita4 Bristol, England, United Kingdom. Inter-
leukin-12 (IL-12) promotes Thl-type T helper cell responses (cell-medi-
ated immunity) and has therapeutic potential in diseases featuring exces-
sive activity of the reciprocal Th2 subset. Mercuric chloride (HgCl2)
induced autoimmunity in Brown Norway (BN) rats is characterized by
selective Th2 activation, and we tested the effects of IL-12 in this model.
Recombinant murine IL-12 (1 pg intraperitoneally for 5 days) was given to
HgCl2 treated BN rats. Controls received IL-12 alone, HgCl2 alone or no
treatment. Serial measurements of serum IgE, IgGI antilaminin antibod-
ies and proteinuria were made and animals were killed at various time
points for preparation of splenic and renal RNA and analysis of cytokmne
gene expression by semiquantitative polymerase chain reaction. HgCl2
alone induced IL-4 mRNA by day 8 and peak serum IgE was on day 14.
Co-administration of IL-i2 delayed IL-4 up-regulation to day 14 and peak
serum IgE to day 21. Interferon-y (IFNy) mRNA expression was in-
creased by day 3 in animals receiving IL-12 or HgCL2 and this was
markedly enhanced in animals receiving both agents. There were no
differences between the groups in IL-12 gene expression, IgGI antilaminin
antibodies or proteinuria. The pattern of cytokine gene expression was
similar in both spleen and kidney. Thus, IL-12 enhanced IFNy gene
expression and markedly delayed the Th2 response. Further experiments
with more prolonged administration of IL-12 are required to test whether
the Th2 response can be abolished altogether. This may have implications
for the treatment of human autoimmune disease including types of
glomerulonephritis.
Renal myofibroblasts predict response to treatment in membranous
nephropathy. NA. Tamimi, P.J. O'Donnell, E.C. Muchaneta-Kubara, PG.
Strange, and AM. El Nahas, Kent and Canterbury Hospital, Department of
Biosciences, University of Kent, Kent, King's College Hospital and Sheffield
Kidney Institute, Sheffield, England, United Kingdom. We have analyzed by
immunohistochemistry (avidin-hiotin-peroxidase) the renal biopsies of 21
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patients with membranous nephropathy (MN) in order to determine
whether the presence of myofibroblasts (identified by their cytoplasmic
expression of a-smooth muscle aetin/a-SMA or Vimentin/V) predicts the
response to treatment. Patients treated by immunosuppression (steroids)
were divided into progressors (P, N = 6) and non-progressors (NP, N =
15) depending on a rise of serum creatinine >20% over an observation
period ranging from 2 to 15 years. Clinical parameters such as hyperten-
sion or proteinuria and conventional histological ones such as the severity
of interstitial infiltrate or fibrosis did not differentiate P from NP. Vascular
sclerosis was statistically more severe in P (P 0.0053). Glomerular
a-SMA was significantly higher in P (0.36 0.22) than in NP (0.17
0.07), P 0.033. Interstitial a-SMA was also higher in P but did not reach
significance. By contrast, interstitial V was higher in P (0.208 0.07);
NP = 0.087 0.05, P = 0.0019). These data suggest that the expression
of glomerular a-SMA and interstitial vimentin predicts the response to
treatment in MN.
Abnormal membrane lipid-cytoskeleton interactions in adult polycystic
kidney disease. K. Vareesangthip, T.H. Thomas, R. Wilkinson, Department
of Medicine (Nephrology), University of Newcastle upon Tyne, Newcastle
upon Tyne. We have previously shown that the red blood cell (rbc)
membrane fluidity in adult polycystic kidney disease (APCKD) patients is
higher than that in normal controls. This difference was found only in
intact rbcs but not in ghost membranes indicating that the cytoskeleton is
abnormal in APCKD. The dynamics of the membrane lipid bilayer are
mainly controlled by the lipid-cytoskeleton interactions. Five APCKD
patients and 5 normal controls (NC) were studied by measuring fluores-
cence anisotropy of the rbc membrane after incubating with liposomes
(Lp) containing antibodies to actin (anti-actin) and ankyrin (anti-ankyrin).
Superficial and core region anisotropies were phobed by trimethyl ammo-
nium-diphenyihexatriene (TMA-DPH) and 1,6-diphenyl-1,3,5-hexatriene(DPH) respectively. Results are shown in the Table.
NC (N = 5)
_______
TMA-DPH DPH
Untreated rbc 0.277 0.002 0.222 0.001
Lp
Anti-actin/Lp
Anti-ankyrin/Lp
0.277 0.002
0.262 0.002
0.262 0002b
0.222 0.001
0.194 0001h
0.196 jy,jh
APCKD (N = 5)
TMA-DPH DPFI
Untreated rbc 0.264 0.OOIa 0.198 0.001
Lp 0.265 0.001' 0.198 0.o0P
Anti-actin/Lp 0.264 0.001 0.197 0.001
Anti-ankyrin/Lp 0.263 0.001 0.197 0.001
Values are mean SEM. ' P < 0.001 for NC and APCKD patients; b p <
0.001 for untreated rbc and after incubation with anti-actin/Lp or anti-
ankyrin/Lp.
Disturbance of cytoskeletal actin and ankyrin clearly caused alterations of
membrane fluidity in NC but not in APCKD patients. This indicates that
the interactions between the lipid bilayer and the cytoskeleton of eryth-
rocyte membranes are abnormal in APCKD.
Transglutaminase intracellularly crosslinks tubule cells and stabilizes
the ECM in kidney fibrosis. T.S. Johnson, M. Griffin, G.L. Thomas, B.
Yang, J. Skill, A. Cox, B. Nicholas, C. Kubara, and A.M. El Nahas, Sheffield
Kidney Institute, Northern General Hospital Trust, Sheffield; Department of
Life Science, Nottingham Trent University, Nottingham, England, United
Kingdom. Transglutaminases (Tg) are a family of calcium-dependent
enzymes that catalyse the cross-linking of polypeptide chains, including
those of extracellular matrix (ECM) proteins, through the formation of
(y-glutamyl) lysine bonds. This leads to the formation of protein polymers
that are highly resistant to degradation. Consequently, tissue Tg have been
associated with ECM protein deposition in fibrotic diseases such as
pulmonary fibrosis and atherosclerosis. We investigated the involvement
of Tg in the development of kidney fibrosis in adult male Wistar rats
submitted to subtotal nephrectomy (SNx). Groups of 4 to 6 rats were
sacrificed on days 7, 30, 90 and 120 after SNx. These rats developed
progressive glomerulosclerosis and tubulointerstitial fibrosis. The tissue
level of (y-glutamyl) lysine crosslink (as determined by exhaustive
proteolytic digestion followed by cation exchange HPLC) increased from
347 94 pm/mg protein (mean SCM) in controls to 1324 143 pm/mg
90 days after SNx, P < 0.01. Levels of crosslink correlated well with the
renal fibrosis score throughout the 120 observation days (r = 0.84, P <
0.01). Tissue homogenates, when corrected for surviving tubule mass
showed significant changes in overall Tg levels as determined by activity
(4C putrescine incorporation assay) increasing from 5.77 0.35 to
13.93 4.21 U/pg DNA (P < 0.01), while Western blot analysis showed
increases in Tg antigen from 829 199 to 5256 2163 U (P < 0.01).
Immunohistochemistry (avidin-biotin-peroxidase) demonstrated that this
large increase in crosslink and Tg was predominantly in the cytoplasm of
tubular cells. Immunofluorescence showed low levels of (y-glutamyl)
lysine bonds in the extracellular environment in scarred tissue. Some of
the cells high in erosslink and Tg displayed morphology typical of a cell
undergoing apoptosis, although the majority of these did not show DNA
cleavage (in situ end labelling) normally associated with apoptosis. We
postulate a dual role for tissue transglutaminases in the development of
experimental renal fibrosis by stabilizing extracellular matrix and the
intracellular crosslinking of proteins leading to cell death.
Effects of verocytotoxin-l on human renal epithelial cells. J.M. Williams,
D. V Milford, and CM. Taylor, Department of Nephrology, The Children's
Hospital, and Renal Research Laboratories, University of Birmingham,
Birmingham, England, United Kingdom. Infection with verocytotoxin-
producing E. coli causes hemolytic uremic syndrome in which endothelial
damage is central to the pathogenesis of the disease. Verocytotoxin-1
(VT1) is cytopathic to certain immortalized cell lines and renal microvas-
cular endothelial cells in culture. Uncertainty surrounds the localization of
VT1 receptor (Gb3) in the kidney. Lingwood (1995) found Gb3 was
localized to the glomerulus and distal convoluted tubule in pediatric renal
sections, whereas both Siegler (1994) and Oosterwijk (1991) found
staining was confined to renal tubular epithelial cells. We provide evidence
that VTI inhibits protein synthesis in primary cultures of glomerular and
proximal tubular epithelial cells. These cells are more sensitive to the
protein synthesis inhibitory effects of VTI than Vero cells (for example, 10
pg/mI reduced protein synthesis to 21.75% over 24 hours). However,
unlike Vero cells apoptosis is not apparent at 24 hours.
Percentage of basal protein synthesis in the presence of VT!
Time (h)
_______
4 10
Glomerular epithelial cells
1 pg/mI 87.0 4.7 54.8 4.2
10 pg/mI 29.1 2.8 14.9 2.0
100 pg/mI 5.7 0.6 2.2 0.5
Proximal tubular epithelial cells
I pg/mI 92 2.7 81.6 2.0
10 pg/mI 50.6 1.0 16.1 0.6
100 pg/mI 3.3 0.2 0.7 0.01
Time (h) 16 24
Glomerular epithelial cells
I pg/mI 45.5 6.7 47.6 4.1
10 pg/mI 7.4 0.9 4.9 0.5
100 pg/mI 1.4 0.3 1.5 0.1
Proximal tubular epithelial cells
I pg/mI 74.1 1.8 76.0 10
10 pg/mI 9.4 0.4 7.1 1.1
100 pg/mI 0 0 0.7 0.2
Mean SD; N = 3
We conclude that VTI induces profound protein synthesis inhibition in
glomerular and proximal tubular epithelial cells without early cytocidal
effects.
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Multilevel modelling of the determinants of acceptance on to renal
replacement therapy in England. P. Roderic?c, S. Clements, N. Stone, D.
Martin, and I. Diamond, Departments of Public Health, Social Statistics,
Geography, Southampton University, Southampton, England, United King-
dom. Background. The National Renal Review in England found an
overall unmet need in renal replacement therapy provision and substantial
variation in age, sex, ethnic and district health authority rates. The higher
ethnic rates found may be partly confounded with the proximity of ethnic
minority populations to renal services and DHA rates partly explained by
"need" based factors such as age, sex, and ethnicity. However, little is
known of the influence of socio-economic factors or the effect of access to
or supply of renal services. Multilevel modelling techniques allow analysis
of individual and real characteristics at the same time. This has been
applied to the Review dataset and this paper will present data on the
independent effects on acceptance rates of need, access and supply factors.
Methods. The Review collected information on each adult patient ac-
cepted onto RRT in England in 1991—1993: 6046 patients were accepted
in 53 renal units, 5715 (94.5%) had valid postcodes and were assigned to
their Census electoral ward. Multilevel modelling with Poisson regression
were used with ward acceptances as the dependent variable. Level 1
dependent variables were age and sex. Level 2 ward factors included
percent Asian or Black, deprivation indices, and accessibility (crow fly
distance or private transport time from ward centroid to renal units) and
supply (nephrology beds or hemodialysis stations/catchment population).
Results and conclusion. The modelling results presented will show the
independent effects of age, sex, ethnicity, social deprivation, travel time
and distance and supply on the RRT acceptance rate for England and
their effects in explaining DHA variations. The implications for under-
standing the epidemiology of ESRF and for the planning of renal services
will be discussed.
